rfhg_238928.1

Basic information about the TSS

---

TSS ID: rfhg_238928.1 Species: human Chr: chrX		Start: 123962011 End: 123962038 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D4308732,EH38E2767239)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000428941.5:0 GeneID: 10735 HGNC/MGI_ID: HGNC:11355 UniProt_ID: B1AMT2 Nearer transcript ids and distances: NM_001375377.1:20 NM_001375372.1:20 ENST00000435215.5:56 ENST00000471107.1:-188 ENST00000466748.5:-236 BC001765:-254 ENST00000458176.5:-272 ENST00000371144.7:-272 BX641003:-272 BX641002:-273 CR749433:-273 AL831939:-273 ENST00000371157.7:-293 ENST00000371145.8:-305 NM_006603.5:-305 NM_001375371.1:-305 NM_001042751.2:-305 NM_001042750.2:-305 view more...

Gene_name: stromal antigen 2 Gene_symbol: STAG2 Gene_synonyms: SA-2 SA2 SCC3B Gene_source: HGNC:11355

TATA-Box annotation

---

Distance to TSS:	318
Nearest PromoterID:	NM_001042751
Entrez ID:	10735
Nearest Unigene:	Hs.496710
Nearest Refseq:	NM_006603
Nearest Ensembl:	ENSG00000101972
Gene Name:	stromal antigen 2
Gene Alias:	NEDXCF|SA-2|SA2|SCC3B|bA517O1.1
Gene Type:	protein-coding
CpG%:	0.037037
GC%:	0.392857
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@STAG2 p2@STAG2 p3@STAG2 p4@STAG2 p5@STAG2 p6@STAG2 p7@STAG2 p8@STAG2 p9@STAG2 p10@STAG2
Sample		p1@STAG2	p2@STAG2	p3@STAG2	p4@STAG2	p5@STAG2	p6@STAG2	p7@STAG2	p8@STAG2	p9@STAG2	p10@STAG2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	41.30	10.91	8.96	8.18	2.53	1.75	2.14	0.97	0.58	2.14
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	38.64	9.31	7.28	8.09	1.21	0.61	2.23	1.42	0.61	1.21
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	44.95	10.61	9.07	8.10	2.89	0.96	3.67	0.39	0.19	2.12
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	37.42	8.73	7.07	8.11	1.46	0.62	1.66	0.42	0.00	1.04
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	40.27	9.67	7.65	7.65	0.90	0.22	2.02	1.12	0.22	1.80
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	41.86	10.47	6.98	5.23	0.58	0.78	1.94	1.55	0.39	1.94
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	54.25	13.07	14.38	5.45	2.61	2.18	2.61	0.87	1.09	4.58
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	50.38	9.20	11.38	6.54	2.66	0.24	1.45	1.21	0.48	3.63
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	44.24	6.41	7.27	9.62	1.07	0.85	2.14	1.28	0.21	1.28
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	49.85	13.33	6.96	10.43	4.06	1.74	2.32	1.16	1.74	3.48
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	42.44	12.53	6.47	16.98	2.83	0.81	2.43	2.02	0.00	2.43
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	43.50	17.08	6.50	13.82	4.47	0.00	1.63	1.22	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	27.89	1.45	0.32	4.67	0.32	0.64	0.16	0.32	0.64	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	26.16	2.86	0.45	3.31	0.30	0.60	0.45	0.00	1.05	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	29.86	1.32	0.66	6.15	0.00	0.66	0.66	0.44	0.44	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	20.12	1.51	0.25	4.02	0.00	0.25	0.50	0.25	0.50	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	21.84	1.31	0.66	4.80	0.00	0.44	0.87	0.22	0.44	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	24.47	1.27	0.42	3.80	0.00	1.27	1.27	0.42	1.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	26.66	0.53	1.07	2.67	0.00	0.53	1.07	0.00	0.53	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	26.48	1.20	0.60	3.16	0.00	0.75	1.35	0.15	0.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	21.25	1.34	0.27	2.54	0.13	0.67	1.34	0.13	0.27	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	26.58	0.86	0.35	1.90	0.17	0.52	0.52	0.35	0.69	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	24.43	1.55	0.13	4.52	0.00	0.90	0.52	0.13	0.65	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	19.41	0.73	0.97	4.61	0.49	0.73	1.21	0.00	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	17.54	1.29	1.03	4.39	0.26	0.77	1.55	0.00	0.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	19.62	0.95	0.32	3.80	0.00	0.95	0.95	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	25.82	2.20	0.00	4.40	0.00	0.55	1.10	0.55	0.00	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	22.40	2.36	0.47	3.06	0.00	0.71	0.71	0.24	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	19.22	0.97	0.00	1.62	0.00	0.65	0.32	0.32	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	21.72	2.17	0.54	2.71	0.18	0.54	1.27	0.36	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	18.84	1.26	0.21	5.02	0.21	0.63	0.63	0.21	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	19.34	0.98	0.20	4.10	0.00	1.17	1.37	0.00	0.39	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	18.57	1.90	0.42	2.32	0.00	1.27	0.00	0.42	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	20.95	3.30	0.82	1.81	0.33	0.49	1.32	0.49	0.82	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	15.52	2.62	0.00	4.49	0.00	0.37	0.56	0.00	0.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	13.99	1.34	0.57	3.26	0.19	0.38	0.57	0.19	0.77	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	14.10	2.04	0.82	2.86	0.41	0.00	0.41	0.20	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	16.32	1.81	0.60	3.63	0.20	0.81	0.60	0.20	0.20	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	12.15	3.24	0.81	4.05	0.54	0.27	0.54	0.00	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	13.20	3.12	0.96	2.64	0.48	0.48	0.24	0.72	1.44	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	9.88	2.35	0.24	2.12	0.00	1.88	0.71	0.94	1.41	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	13.32	2.49	0.73	1.90	0.59	0.73	0.15	0.00	1.02	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	10.54	1.48	0.42	6.12	0.42	0.63	0.63	0.00	0.21	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	13.46	2.62	0.52	5.24	0.35	1.05	0.35	0.00	1.05	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	15.26	4.02	0.60	4.22	0.40	0.80	0.60	0.80	1.61	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	8.84	1.86	0.47	6.28	0.00	0.70	0.70	0.23	1.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	10.80	1.92	0.48	7.44	0.48	0.96	0.24	0.24	1.92	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	14.01	2.38	1.49	3.58	0.30	2.09	0.00	0.30	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	13.40	1.91	0.72	4.79	0.24	1.44	0.72	0.48	1.44	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	15.16	3.24	0.40	5.46	0.40	1.01	0.00	0.20	0.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	15.58	3.28	0.61	1.84	0.20	1.43	0.20	0.41	1.43	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	12.01	2.89	0.67	3.11	0.67	0.67	0.89	0.22	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	97.95	0.00	0.00	125.93	0.00	41.98	13.99	0.00	13.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	7.10	1.77	0.35	2.48	0.35	0.71	0.35	0.35	0.35	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	7.62	1.33	0.33	3.65	0.00	0.99	0.33	0.00	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	30.20	5.87	3.36	5.03	2.52	4.19	0.84	0.00	5.03	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	17.91	5.05	0.00	1.84	0.92	3.67	0.46	0.92	3.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	13.94	1.62	0.32	7.45	0.32	0.00	0.00	0.32	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	9.64	0.96	0.32	5.14	0.00	0.32	0.32	0.32	0.00	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	18.55	5.34	0.00	4.09	0.63	3.14	0.63	0.31	0.94	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	11.99	1.41	0.00	7.05	0.00	0.00	0.00	0.00	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	12.34	3.36	0.56	5.61	1.12	0.00	0.00	0.56	1.68	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	28.66	7.96	0.00	5.57	1.59	3.98	0.00	1.59	1.59	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	19.37	5.44	0.34	4.08	0.34	0.34	0.34	0.34	0.68	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	13.32	1.30	0.00	8.45	0.00	0.65	0.00	0.32	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	9.58	2.48	0.00	5.68	0.71	1.06	0.35	0.00	2.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	177.80	32.33	16.16	242.46	32.33	16.16	0.00	32.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	47.38	23.69	7.90	86.87	23.69	15.79	0.00	7.90	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	12.19	0.49	0.49	4.39	0.00	1.46	0.00	0.00	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	14.88	1.49	0.00	3.97	0.99	0.00	0.00	0.00	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	9.85	0.00	0.47	1.88	0.00	1.88	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	19.21	1.99	1.32	2.65	0.33	0.99	0.00	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	18.25	1.86	1.24	6.19	0.00	0.31	0.62	0.00	0.31	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	16.51	0.61	0.92	6.11	0.00	0.00	0.00	0.00	0.61	0.00
Adipocyte - breast, donor1	11376-118A8	13.15	2.22	0.32	0.95	0.63	0.79	0.48	0.16	1.43	0.00
Adipocyte - breast, donor2	11327-117E4	9.63	3.21	0.16	0.64	0.16	0.32	0.32	0.16	0.80	0.00
Adipocyte - omental, donor1	11473-119C6	11.20	5.60	0.13	1.65	0.13	1.02	0.25	0.51	1.02	0.00
Adipocyte - omental, donor2	11474-119C7	2.24	0.75	0.00	0.75	0.00	0.00	0.00	0.00	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	8.04	0.33	0.00	0.67	0.00	0.00	0.33	0.33	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	7.02	1.28	0.64	1.28	0.00	0.00	0.64	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	4.40	1.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	7.23	0.90	0.00	0.45	0.45	0.45	0.00	0.00	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	5.21	0.52	0.00	0.35	0.00	0.17	0.52	0.17	0.35	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	39.11	10.17	1.17	1.76	3.13	0.98	0.59	1.37	0.59	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	21.36	7.21	0.51	0.00	1.80	0.26	1.54	2.06	0.51	0.77
Adipocyte differentiation, day04, donor3	13025-139E1	29.55	6.13	0.28	2.23	1.67	1.39	1.39	1.39	0.84	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	28.80	8.82	0.00	2.94	2.35	1.18	0.59	0.00	1.76	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	18.42	8.28	0.00	4.75	0.80	2.41	1.21	0.72	1.77	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	20.98	8.39	0.65	2.26	0.97	0.32	2.26	1.61	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	16.53	9.06	0.53	1.07	1.07	0.00	1.07	2.13	2.13	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	10.57	7.79	0.00	3.34	0.00	0.56	1.11	2.23	1.11	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	9.57	2.08	0.00	2.08	0.42	0.00	0.83	0.00	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	13.06	5.02	0.00	1.51	1.26	1.00	0.50	0.50	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	9.82	6.54	0.33	0.33	0.65	0.00	0.65	1.31	0.98	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	8.53	4.57	0.00	3.04	0.00	0.91	0.61	0.30	1.83	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	3.54	0.44	0.00	0.22	0.00	0.00	0.00	0.22	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	1.08	0.00	0.00	0.72	0.36	0.00	0.00	0.36	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	2.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	5.76	1.62	0.54	1.08	0.00	0.36	0.36	0.18	0.72	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	3.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	3.49	0.82	0.21	0.41	0.00	0.00	0.00	0.00	0.21	0.00
Anulus Pulposus Cell, donor1	11248-116E6	32.73	5.26	1.37	0.92	0.46	1.60	1.95	0.46	1.03	0.46
Anulus Pulposus Cell, donor2	11463-119B5	26.69	1.22	0.73	1.71	0.24	0.98	0.73	0.98	0.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	13.48	2.70	0.45	0.90	1.35	0.00	0.90	1.35	1.80	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	15.63	3.04	0.00	1.74	0.43	0.00	0.43	0.87	0.87	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	23.54	2.14	0.00	0.00	6.42	2.14	0.00	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	16.14	3.89	0.30	1.20	0.60	0.60	1.49	0.60	0.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	10.12	5.06	0.00	0.00	0.00	1.26	0.00	0.00	3.79	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	13.86	1.32	0.66	0.66	0.66	0.66	0.00	0.00	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	13.32	2.60	0.32	0.32	0.97	0.32	0.32	0.65	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	14.08	3.88	0.49	0.49	0.97	0.97	0.97	0.97	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	7.72	3.56	1.78	0.59	0.00	0.59	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	18.83	4.14	1.13	0.38	1.51	0.38	0.38	1.13	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	13.79	5.08	0.00	0.73	0.00	0.00	0.00	0.73	0.73	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	10.03	1.25	0.00	0.00	1.25	1.25	2.51	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	17.46	2.80	0.49	1.15	0.82	0.33	0.16	0.16	1.32	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	13.65	4.09	1.36	0.00	0.00	2.73	0.00	0.00	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	9.65	2.26	0.15	0.30	0.30	0.30	0.30	0.30	0.45	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	17.68	4.82	0.00	0.54	0.00	1.07	0.54	2.14	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	10.58	3.02	0.38	0.19	0.94	0.38	0.76	0.19	0.57	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	14.17	2.41	0.27	1.60	1.07	1.07	0.53	0.27	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	11.71	4.88	1.95	0.00	0.98	0.00	0.00	0.98	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	14.26	2.16	0.83	0.50	0.83	0.33	0.66	0.17	0.66	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	8.41	1.20	0.00	0.00	0.00	0.00	0.00	0.00	1.20	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	14.16	10.62	3.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	13.38	2.74	0.17	0.86	0.51	1.03	0.51	1.03	1.03	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	0.00	4.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	12.14	4.37	0.97	0.97	1.46	0.49	1.46	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	8.73	3.42	0.76	0.38	0.00	1.14	1.14	1.14	0.76	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	12.11	2.42	2.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	8.55	1.71	0.00	0.00	0.57	0.00	0.57	0.00	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	14.32	2.14	0.00	0.21	0.64	0.00	0.21	0.64	0.64	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	9.29	1.81	0.52	0.52	0.00	0.26	0.00	0.77	0.77	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	13.61	0.47	0.47	0.47	0.94	0.94	0.00	0.47	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	11.58	0.32	0.00	0.64	0.32	0.32	0.96	0.64	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	8.56	3.57	0.00	0.00	0.00	0.00	0.71	0.71	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	11.70	1.17	0.58	0.00	0.00	0.00	0.00	0.00	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	13.25	5.12	0.30	0.60	0.00	0.30	0.00	1.20	0.90	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	7.13	1.19	0.00	0.00	0.00	1.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	16.27	3.05	1.53	1.02	0.51	0.51	0.00	1.53	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	16.05	3.82	0.51	0.51	0.76	1.27	0.25	1.53	0.51	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	7.62	3.18	1.27	0.64	0.00	0.64	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	15.10	2.16	0.00	1.29	0.86	0.00	0.43	0.00	1.73	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	15.24	1.69	0.21	1.27	0.42	0.21	0.64	0.42	1.48	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	9.28	0.87	0.00	0.00	0.00	0.00	0.00	0.29	0.58	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	11.34	5.67	1.89	1.89	0.94	0.94	0.00	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	11.87	3.39	0.17	0.85	0.17	0.51	0.51	1.02	0.85	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	9.27	2.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	23.24	8.45	0.00	0.00	0.00	0.00	2.11	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	12.22	1.93	0.21	0.21	0.21	1.29	0.64	0.21	1.29	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	2.41	3.61	0.00	1.20	0.00	0.60	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	10.21	2.19	0.73	1.46	0.73	1.46	0.00	0.73	1.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	13.10	1.84	0.46	1.15	0.46	0.00	0.69	0.92	0.69	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	12.75	0.00	2.55	0.00	2.55	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	13.73	2.54	0.00	0.00	1.02	0.25	0.25	0.25	0.25	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	15.48	3.72	0.41	0.62	0.83	0.41	0.83	0.21	0.83	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	8.57	3.98	0.31	0.31	0.61	0.31	0.61	1.22	0.92	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	15.30	1.43	1.43	0.00	1.91	0.96	0.00	1.43	1.91	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	10.64	3.10	0.22	0.89	0.67	0.22	0.22	0.44	0.89	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	7.63	3.05	1.53	0.00	1.53	0.00	1.53	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	7.20	4.98	0.00	1.11	2.22	0.00	0.00	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	16.95	1.85	0.53	1.06	0.26	0.53	0.26	0.00	0.79	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	7.63	3.63	1.09	0.00	0.73	0.00	0.73	0.36	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	9.95	1.23	1.84	1.47	0.98	0.00	0.86	0.61	0.12	0.61
Astrocyte - cerebellum, donor2	11580-120F5	3.25	0.68	0.86	0.68	0.68	0.00	0.17	0.34	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	2.73	0.21	0.63	0.00	0.00	0.21	0.63	0.00	0.21	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	38.69	8.02	13.25	3.83	2.09	1.74	4.53	2.09	1.05	3.83
Astrocyte - cerebral cortex, donor2	11316-117D2	31.06	7.77	8.09	5.34	1.78	0.97	1.29	1.29	0.32	1.13
Astrocyte - cerebral cortex, donor3	11392-118C6	35.20	4.77	8.80	3.58	1.34	0.89	1.34	1.79	1.34	1.19
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	30.16	22.82	16.74	10.90	10.55	2.64	0.80	6.88	0.69	3.21
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	32.20	25.18	17.04	10.77	10.15	1.75	0.75	7.89	1.00	2.76
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	31.18	23.90	20.03	11.83	9.45	2.73	0.57	6.03	1.02	3.30
Basophils, donor1	12241-129G9	18.83	5.75	0.00	0.00	11.77	0.52	1.57	2.62	0.78	0.00
Basophils, donor2	12242-129H1	49.43	19.84	2.53	0.36	26.34	2.53	0.72	5.05	2.53	0.36
Basophils, donor3	12243-129H2	33.52	4.56	1.76	2.35	9.85	1.76	1.03	1.47	0.59	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	3.02	0.00	0.22	0.22	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	1.83	0.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	16.32	1.26	1.26	2.51	0.00	0.63	1.88	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	9.77	0.21	0.21	0.83	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	9.44	0.46	0.23	1.15	0.00	0.00	0.23	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	25.73	1.08	0.18	3.42	0.18	0.00	0.72	0.18	0.36	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	32.26	18.55	26.28	2.78	11.75	4.95	0.52	5.67	1.65	2.99
Burkitt's lymphoma cell line:RAJI	10476-106I8	40.53	23.52	20.96	1.86	17.93	3.73	0.70	6.52	2.10	2.10
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	56.60	14.71	7.99	0.64	16.31	1.92	1.92	5.12	0.00	2.24
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	20.68	0.00	0.00	20.68	10.34	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	41.14	13.53	0.00	0.00	24.80	3.38	1.13	4.51	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	41.39	15.22	0.37	3.34	10.76	0.74	2.04	3.34	1.11	0.00
CD14+ Monocytes, donor3	11381-118B4	34.47	9.00	0.00	2.20	20.86	0.44	0.66	2.63	0.88	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	42.74	17.83	0.57	1.13	8.21	1.13	7.93	3.68	0.85	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	41.70	13.65	1.90	0.76	8.72	1.14	8.34	7.20	0.76	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	59.83	14.14	1.31	1.64	7.56	0.99	8.55	4.60	2.30	0.99
CD14+ monocytes - mock treated, donor1	11863-125A9	77.19	12.58	0.72	3.32	5.93	1.59	5.78	2.17	1.45	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	67.29	9.96	2.41	3.92	5.43	0.91	7.54	1.51	2.11	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	72.25	12.56	0.47	2.37	9.00	0.95	4.74	0.71	0.24	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	56.41	14.06	0.67	0.84	6.53	0.84	3.35	2.01	0.50	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	51.06	11.59	0.55	1.38	5.52	1.38	3.86	1.66	0.28	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	61.73	16.12	0.74	2.23	9.92	0.25	3.47	2.23	0.74	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	46.80	17.62	0.98	1.37	2.74	0.59	2.55	1.57	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	49.14	12.29	0.71	2.67	6.05	0.71	3.20	2.49	0.71	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	73.78	18.50	0.65	1.31	9.14	1.74	4.35	1.96	1.09	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	67.19	19.90	0.23	2.11	11.24	0.47	3.51	3.28	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	88.18	17.95	0.00	0.53	11.62	1.06	3.17	2.64	1.06	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	65.45	24.41	1.11	2.22	13.31	2.22	13.31	3.33	1.11	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	60.39	15.77	0.30	1.78	5.35	0.89	4.16	1.49	1.04	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	58.07	13.17	1.40	1.60	3.19	1.40	7.38	1.00	0.20	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	78.70	21.86	0.62	1.87	11.66	1.67	7.70	3.96	1.67	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	67.03	24.48	1.14	2.75	10.75	0.46	6.63	1.83	0.69	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	82.34	21.26	1.13	0.45	11.76	2.04	5.88	4.75	1.58	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	63.72	20.51	0.87	0.87	8.73	1.31	2.62	3.06	1.31	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	61.87	16.68	0.81	2.69	7.26	1.34	4.03	1.08	0.54	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	73.80	10.99	1.22	2.27	4.54	0.70	4.54	1.57	1.22	0.52
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	73.64	13.89	0.42	2.52	5.89	2.52	1.68	2.52	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	61.73	29.21	0.55	1.84	11.02	1.65	4.59	3.86	0.73	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	50.73	24.66	1.41	1.06	16.56	0.70	4.93	4.93	1.41	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	54.40	28.52	0.88	1.75	19.30	0.88	4.39	5.26	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	48.48	12.38	0.35	1.74	4.36	1.05	2.79	1.39	0.35	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	46.46	8.92	0.00	1.49	3.35	1.49	4.09	1.49	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	91.61	18.97	0.86	1.29	8.84	0.43	5.39	2.16	1.51	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	62.24	21.29	1.64	4.91	10.65	0.82	1.64	0.82	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	78.12	28.28	0.23	0.23	16.92	1.16	6.95	5.10	1.62	0.46
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	87.23	38.51	1.16	0.70	25.06	1.62	6.96	7.42	0.93	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	64.95	2.40	1.53	1.31	1.31	0.87	7.85	0.44	0.65	0.87
CD14+CD16+ Monocytes, donor2	11801-124D1	56.59	7.16	0.46	1.62	3.46	1.15	6.24	0.46	0.92	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	49.61	3.90	1.08	0.87	2.82	0.87	8.01	0.65	0.22	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	95.92	7.63	0.62	1.71	3.58	1.40	6.23	0.78	0.78	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	83.31	8.91	1.05	1.40	3.49	1.22	6.11	1.05	1.05	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	153.40	15.16	0.89	3.34	6.47	2.23	11.37	1.56	0.45	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	51.03	2.30	0.77	0.26	0.26	0.77	9.44	0.51	0.51	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	70.04	2.85	1.76	2.20	1.32	0.66	12.08	0.44	0.00	0.66
CD14-CD16+ Monocytes, donor3	11911-125G3	61.06	3.58	1.26	1.47	1.68	1.68	9.69	0.21	0.21	0.63
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	20.32	20.32	0.00	0.00	8.13	4.06	0.00	2.03	2.03	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	25.09	26.44	10.85	1.36	15.59	13.56	0.68	4.07	0.00	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	32.10	18.64	8.28	4.14	13.46	12.43	0.00	6.21	3.11	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	43.71	26.12	7.46	1.07	21.85	21.32	1.60	9.06	3.20	2.67
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	39.67	28.41	9.65	4.29	15.55	28.41	1.07	6.43	2.14	3.22
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	27.38	30.18	3.51	0.70	11.23	13.34	0.00	6.32	2.11	2.81
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	26.67	28.24	2.35	0.78	11.77	17.26	0.00	4.71	1.57	2.35
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	36.91	34.28	7.91	1.32	10.55	21.09	1.32	9.23	1.32	1.32
CD19+ B Cells, donor1	11544-120B5	34.52	24.66	9.04	18.90	20.55	4.93	0.00	4.11	3.29	0.00
CD19+ B Cells, donor2	11624-122B4	20.31	24.66	5.08	10.16	14.51	2.90	0.00	7.25	1.45	1.45
CD19+ B Cells, donor3	11705-123B4	18.17	25.75	4.04	9.59	15.65	6.06	0.00	2.52	1.51	1.51
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	256.98	60.20	51.72	6.46	5.66	4.85	8.08	6.06	2.42	9.70
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	156.60	33.56	40.75	3.99	1.20	5.59	5.99	2.40	1.60	9.59
CD34+ Progenitors, donor1	11545-120B6	32.13	7.03	1.00	0.00	18.07	2.01	2.01	6.02	2.01	0.00
CD34+ Progenitors, donor2	11625-122B5	37.64	12.36	3.37	0.56	29.78	1.12	2.81	14.05	1.69	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	48.85	9.39	10.90	1.50	10.15	1.13	1.50	4.51	0.38	3.01
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	48.03	16.01	12.63	0.45	9.02	3.83	1.80	3.83	1.35	3.38
CD4+ T Cells, donor1	11225-116C1	40.70	36.42	3.93	3.93	75.70	6.07	0.00	19.28	4.64	1.07
CD4+ T Cells, donor2	11306-117C1	15.92	33.68	3.06	7.35	36.13	3.67	1.84	7.35	1.84	0.61
CD4+ T Cells, donor3	11382-118B5	25.62	28.06	0.91	5.18	26.23	6.40	0.00	9.76	2.44	0.61
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	47.73	22.21	3.57	5.36	8.68	4.59	0.51	5.62	1.28	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	38.41	19.32	2.02	4.49	8.31	6.06	0.00	3.82	0.45	1.35
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	37.37	15.24	2.87	4.02	6.61	4.60	0.57	3.45	0.57	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	37.93	23.70	3.32	0.47	18.49	8.53	0.47	6.64	2.84	1.90
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	29.50	23.18	7.02	2.81	26.69	5.62	0.00	9.13	5.62	2.11
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	19.78	9.89	6.59	3.30	13.18	0.00	0.00	6.59	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	38.01	15.32	2.60	4.34	12.72	5.20	0.43	4.48	2.60	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	31.35	9.66	1.86	3.22	4.91	3.73	0.68	1.86	1.02	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	24.99	9.19	2.58	4.67	5.48	1.93	0.32	3.71	0.97	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	31.83	13.90	4.03	2.69	14.35	5.83	0.90	2.24	1.34	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	35.64	16.42	5.59	5.24	9.08	7.34	0.00	2.45	2.45	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	59.84	27.72	7.92	1.76	17.16	6.16	0.44	5.28	3.96	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	42.16	19.82	3.37	4.22	14.34	5.48	0.84	5.06	0.84	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	34.28	17.04	3.12	3.12	8.52	2.08	0.21	3.32	0.62	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	26.73	13.37	1.34	4.68	6.35	4.01	0.33	3.01	1.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	40.79	38.89	5.71	5.71	26.65	12.51	0.54	9.25	1.90	1.09
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	49.84	38.59	6.97	9.11	32.16	16.61	0.00	13.40	3.22	2.68
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	34.07	25.11	0.00	0.00	10.76	12.55	0.00	7.17	3.59	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	39.50	28.56	5.75	5.38	15.76	3.15	0.56	5.93	1.30	0.93
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	27.51	17.76	2.60	3.68	7.80	2.60	0.22	4.12	1.30	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	28.79	14.08	3.15	5.67	9.67	3.36	0.63	3.36	0.42	0.84
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	24.77	20.22	2.53	1.01	25.79	5.56	1.01	6.07	1.52	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	33.36	21.23	4.33	1.73	18.63	6.50	0.00	3.47	2.17	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	61.89	33.12	3.49	1.74	37.92	11.77	0.00	11.77	1.74	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	45.03	34.64	2.47	1.48	27.22	10.89	0.99	5.94	2.47	1.48
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	33.23	29.54	2.77	0.00	20.31	8.31	0.92	7.39	2.77	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	20.94	26.52	2.79	0.00	25.12	13.96	0.00	8.37	5.58	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	57.88	29.63	5.82	2.49	34.89	6.37	2.22	14.95	2.77	1.38
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	74.35	31.66	9.08	4.17	34.35	10.31	0.98	17.18	4.17	1.96
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	50.82	27.72	7.70	3.08	27.72	15.40	0.00	9.24	1.54	3.08
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	55.15	38.32	4.66	2.15	32.95	16.47	2.15	11.82	4.30	2.51
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	30.47	23.54	1.38	1.38	48.47	15.23	2.77	6.92	1.38	1.38
CD8+ T Cells, donor1	11226-116C2	21.94	21.61	2.62	3.60	59.91	8.18	0.00	7.86	3.60	1.96
CD8+ T Cells, donor2	11307-117C2	13.14	19.15	2.63	6.01	39.04	2.25	0.00	6.38	2.63	1.13
CD8+ T Cells, donor3	11383-118B6	14.90	29.54	3.53	4.04	57.32	3.28	0.50	9.85	2.27	0.76
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	5.51	2.52	5.05	2.75	2.06	0.46	0.23	1.15	0.23	1.38
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	10.30	3.12	3.83	2.88	0.96	0.00	0.96	0.72	0.72	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	8.21	5.75	4.10	2.74	1.37	0.55	0.27	0.27	0.27	0.82
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	12.61	3.30	7.21	0.30	2.70	0.30	0.30	1.50	0.30	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	8.64	2.16	5.04	1.92	2.16	0.24	0.48	0.96	0.48	1.68
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	10.46	2.27	4.55	3.64	0.68	0.00	0.23	0.91	0.45	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	14.78	3.69	9.34	2.82	2.17	0.00	0.87	2.17	0.43	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	16.85	4.21	9.21	4.47	1.84	0.26	0.53	0.79	0.53	0.79
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	17.82	3.52	8.68	5.16	1.17	0.23	0.70	1.41	0.23	1.64
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	18.11	4.23	7.25	3.02	3.62	0.30	1.21	1.81	0.30	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	16.27	2.91	9.30	5.23	2.32	0.87	0.87	0.87	0.58	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	12.79	3.73	8.79	5.60	1.87	0.27	0.53	1.07	0.80	1.07
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	19.26	5.69	9.19	7.88	5.25	0.00	1.31	0.44	0.00	1.31
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	16.40	3.64	12.75	5.47	3.64	0.00	0.46	2.28	0.46	1.82
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	25.36	4.48	8.20	14.92	3.73	0.00	1.49	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	7.20	2.16	5.04	3.24	0.72	0.00	0.36	0.72	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	8.34	2.59	4.32	3.16	2.01	0.00	0.86	1.44	0.00	0.86
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	9.66	3.30	2.59	2.59	2.12	0.00	0.00	0.71	0.24	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	14.89	1.90	7.61	3.49	2.85	0.32	1.58	2.54	0.32	0.95
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	14.76	4.00	10.46	1.85	2.15	0.00	0.92	2.15	0.31	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	13.46	2.89	9.30	1.92	2.56	0.32	1.60	1.92	0.32	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	15.68	4.59	9.56	2.68	1.53	0.00	0.76	0.76	0.38	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	18.13	5.12	7.88	4.34	1.97	0.00	0.39	1.18	0.39	1.18
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	12.10	5.29	5.29	7.56	2.27	0.00	0.00	0.76	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	24.09	15.26	16.06	8.83	11.24	0.80	2.41	4.01	0.80	2.41
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	25.88	13.29	13.29	7.69	9.79	0.00	1.40	8.39	0.70	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	21.04	13.02	26.05	12.02	15.03	0.00	3.01	6.01	2.00	3.01
Cardiac Myocyte, donor1	11525-119I4	5.48	5.48	0.00	3.66	0.00	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	13.83	4.94	0.49	1.98	0.49	0.99	0.49	0.49	0.99	0.00
Cardiac Myocyte, donor3	11686-122I3	16.63	2.53	0.95	1.16	1.05	1.26	0.42	0.95	0.42	0.00
Chondrocyte - de diff, donor1	11261-116G1	29.12	4.85	1.04	1.73	1.39	0.69	1.04	2.43	0.69	0.00
Chondrocyte - de diff, donor2	11338-117F6	12.08	3.55	0.36	0.00	0.36	0.00	0.00	0.00	0.00	0.36
Chondrocyte - de diff, donor3	11410-118E6	17.29	2.96	0.57	0.80	0.57	1.25	0.46	0.11	1.25	0.00
Chondrocyte - re diff, donor2	11339-117F7	11.64	2.69	0.90	1.79	0.00	0.00	0.00	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	7.68	2.43	0.40	0.81	0.00	1.62	0.81	0.00	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	34.08	8.72	6.77	3.56	4.48	1.15	1.26	2.52	1.38	1.61
Ciliary Epithelial Cells, donor2	11323-117D9	19.24	4.49	1.50	3.21	2.99	1.92	0.86	1.92	2.57	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	17.17	4.16	1.42	2.48	2.30	0.97	0.62	0.97	0.88	0.80
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	21.09	7.52	0.83	2.20	1.65	1.83	1.38	1.38	1.28	0.09
Corneal Epithelial Cells, donor1	11526-119I5	3.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	11.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	5.62	0.00	0.77	0.51	0.00	0.26	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	8.25	3.80	0.00	2.97	3.47	0.66	0.33	0.50	0.50	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	6.31	3.15	0.32	1.26	2.52	0.95	1.26	0.63	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	10.35	6.90	0.00	0.00	0.00	3.45	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	6.37	2.05	0.00	1.62	0.76	0.32	0.11	0.22	0.32	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	41.68	19.82	5.81	1.71	27.67	4.44	1.02	3.42	4.10	2.73
Dendritic Cells - plasmacytoid, donor2	11309-117C4	35.91	22.85	6.53	0.65	36.56	9.14	0.65	5.22	1.96	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	42.10	14.52	8.23	0.48	25.17	1.94	1.45	5.81	1.45	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	12.84	3.34	0.83	0.17	0.33	0.00	0.17	1.00	0.33	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	7.04	1.76	1.17	0.59	0.59	0.00	0.00	0.59	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	8.20	2.55	0.28	0.00	0.28	0.28	0.00	0.28	0.00	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	5.50	2.36	0.39	0.39	0.79	0.00	0.00	0.79	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	8.14	0.87	0.00	0.29	0.00	0.29	0.58	0.29	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	14.82	4.71	1.65	1.65	1.18	0.71	0.94	0.71	0.47	0.00
Endothelial Cells - Artery, donor3	11413-118E9	7.71	2.80	0.70	0.53	1.40	0.35	0.18	1.05	0.00	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	22.17	3.77	1.55	1.11	3.10	1.55	0.44	1.99	0.22	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	27.99	7.00	0.91	2.43	3.35	0.61	0.91	2.13	0.61	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	33.26	7.05	1.41	1.69	4.79	1.41	1.13	5.64	2.82	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	7.43	1.49	0.00	0.59	1.19	0.00	0.30	0.59	0.00	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	7.81	3.64	0.52	1.56	1.04	0.00	0.52	0.00	0.00	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	3.12	0.99	0.00	0.14	1.13	0.14	0.00	0.43	0.28	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	32.01	4.00	3.20	3.60	1.60	0.40	0.40	2.40	0.00	1.20
Endothelial Cells - Thoracic, donor2	11343-117G2	5.24	1.05	0.00	0.00	1.05	0.00	0.52	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	47.21	17.77	8.08	3.85	6.34	0.87	1.62	2.48	1.62	1.49
Endothelial Cells - Umbilical vein, donor2	11324-117E1	30.42	9.78	3.04	4.35	4.78	0.65	0.43	3.26	0.22	1.09
Endothelial Cells - Umbilical vein, donor3	11400-118D5	32.73	9.65	3.54	4.15	3.91	0.73	0.37	1.34	0.85	0.85
Endothelial Cells - Vein, donor1	11267-116G7	5.69	1.14	0.00	1.14	0.00	0.00	0.00	0.00	0.00	1.14
Endothelial Cells - Vein, donor2	11344-117G3	4.89	1.40	0.70	0.70	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	12.56	4.08	0.47	1.57	1.41	0.47	0.47	0.31	0.47	0.00
Eosinophils, donor1	12244-129H3	76.23	45.74	0.00	0.00	30.49	0.00	0.00	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	191.43	29.70	0.00	0.00	69.31	6.60	13.20	13.20	1.65	1.65
Eosinophils, donor3	12246-129H5	142.67	24.97	3.57	0.00	99.87	0.00	0.00	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	2.93	0.00	0.24	0.73	0.00	0.24	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	0.00	0.00	2.08	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	16.83	2.87	0.00	2.46	0.00	0.82	0.00	1.23	1.64	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	5.47	0.77	0.11	0.00	0.33	0.88	0.11	0.33	0.55	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	8.45	3.14	0.33	1.30	0.22	0.33	0.54	0.22	0.54	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	17.46	6.91	1.21	1.82	1.21	0.73	0.36	0.97	0.85	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	37.39	7.10	0.55	1.36	1.36	1.09	1.36	1.36	2.05	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	9.70	3.06	0.11	1.58	0.53	0.74	0.63	0.11	0.74	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	26.09	5.53	1.05	2.63	0.79	0.00	1.32	2.11	0.53	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	14.95	5.32	1.99	2.66	1.00	0.66	0.33	0.33	0.66	0.33
Fibroblast - Cardiac, donor1	11268-116G8	9.07	1.81	0.45	1.81	0.00	0.45	0.00	0.45	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	5.31	0.76	0.76	0.76	0.00	0.00	0.00	0.00	1.52	0.00
Fibroblast - Cardiac, donor3	11417-118F4	3.15	2.05	0.00	0.32	0.47	0.16	0.16	0.16	0.95	0.00
Fibroblast - Cardiac, donor4	11452-119A3	43.95	6.06	1.21	1.52	1.82	2.42	1.52	1.82	2.42	0.00
Fibroblast - Cardiac, donor5	11456-119A7	25.13	3.05	0.51	3.17	0.63	0.51	0.63	1.14	0.76	0.38
Fibroblast - Cardiac, donor6	11460-119B2	24.41	3.64	1.67	1.67	1.06	0.15	0.61	1.52	0.15	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	9.65	1.88	0.13	0.27	0.54	0.40	0.40	2.01	0.40	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	17.69	3.02	0.43	1.29	3.88	0.00	0.43	0.00	0.86	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	20.51	0.00	4.39	2.93	0.00	0.00	2.93	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	15.45	1.85	0.92	0.46	0.46	0.00	0.46	0.46	0.23	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	45.96	7.46	2.71	2.20	1.02	1.19	4.07	1.02	1.02	0.68
Fibroblast - Dermal, donor1	11269-116G9	19.25	1.88	1.17	0.23	0.70	0.47	0.23	0.23	0.23	0.00
Fibroblast - Dermal, donor2	11346-117G5	9.91	1.42	0.94	0.47	0.00	0.00	0.00	1.42	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	15.59	1.45	0.60	0.73	0.85	0.60	0.85	0.48	0.97	0.12
Fibroblast - Dermal, donor4	11450-119A1	44.09	4.97	9.38	3.96	0.23	0.23	1.24	0.79	0.79	0.79
Fibroblast - Dermal, donor5	11454-119A5	45.88	6.63	9.94	4.01	0.70	1.05	0.52	0.70	0.17	1.40
Fibroblast - Dermal, donor6	11458-119A9	47.10	3.09	11.04	5.04	0.49	0.00	1.62	0.65	0.16	1.79
Fibroblast - Gingival, donor1	11237-116D4	46.85	4.58	2.71	0.83	1.04	1.67	0.42	0.62	1.67	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	27.25	6.29	0.52	2.62	0.79	1.05	0.26	0.26	1.57	0.00
Fibroblast - Gingival, donor2	11318-117D4	30.18	4.09	4.61	2.24	0.13	0.26	1.19	0.79	1.05	0.79
Fibroblast - Gingival, donor3	11394-118C8	60.82	4.06	0.39	3.58	0.39	1.16	1.35	0.87	1.06	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	31.17	13.51	1.04	1.04	2.08	0.00	1.04	0.00	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	17.44	5.29	0.00	1.59	0.35	0.70	0.53	0.53	0.18	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	29.93	10.76	5.46	3.27	0.16	0.62	0.47	2.03	1.71	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	35.56	4.06	3.92	2.57	1.35	0.27	0.81	1.35	1.22	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	5.29	1.76	0.00	1.76	0.71	0.35	0.00	0.00	0.00	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	29.98	7.17	1.61	2.34	0.29	1.17	0.88	0.88	0.88	0.73
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	30.27	7.91	3.68	2.86	1.09	0.82	0.14	0.41	1.50	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	34.66	10.42	5.59	5.05	0.44	0.33	0.99	0.99	1.97	0.99
Fibroblast - Gingival, donor9 (control)	11927-125I1	41.82	7.92	0.73	1.91	0.44	1.76	1.17	0.59	1.76	0.15
Fibroblast - Lung, donor1	11270-116H1	8.16	2.72	1.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	56.70	5.97	7.46	2.98	0.00	1.49	1.49	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	14.56	1.90	1.69	1.90	0.63	0.42	0.21	0.84	0.63	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	5.00	0.00	0.00	0.00	1.67	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	4.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	1.12	0.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	8.12	2.03	1.62	1.22	0.41	0.00	0.00	0.81	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	0.00	0.00	0.00	3.99	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	0.00	0.00	0.00	0.00	5.96	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	45.97	4.66	6.98	2.52	1.16	1.16	1.75	0.78	0.39	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	52.33	8.80	9.56	3.49	1.06	0.61	0.91	1.37	1.06	1.82
Fibroblast - Periodontal Ligament, donor3	11395-118C9	61.50	6.43	4.59	1.84	2.75	1.22	1.22	2.45	1.84	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	23.28	3.82	1.53	3.43	0.00	0.00	0.76	0.76	0.38	1.14
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	13.77	4.59	0.81	1.62	0.54	0.54	0.54	0.27	2.16	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	19.02	4.64	0.58	1.39	0.70	0.93	0.23	0.81	0.93	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	14.04	5.20	2.10	0.99	1.44	0.33	0.33	1.33	0.55	0.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	5.69	1.42	1.63	0.61	0.41	0.00	0.20	0.41	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	7.35	1.34	0.00	0.67	0.67	0.00	0.00	0.00	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	16.21	0.79	0.79	1.19	0.00	1.19	0.40	0.79	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	45.64	7.14	10.72	7.94	1.79	1.19	0.60	1.98	0.40	1.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	27.89	5.68	0.36	2.49	0.89	1.60	1.07	1.07	0.53	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	26.41	5.12	1.77	2.56	0.59	0.59	0.39	0.20	1.58	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	32.79	5.42	4.81	4.21	1.50	0.60	1.50	1.20	0.60	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	49.23	5.40	2.91	3.02	0.76	0.32	1.40	1.40	0.97	0.54
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	41.25	6.33	1.27	5.06	1.77	0.00	1.01	1.77	0.51	0.51
Fibroblast - skin normal, donor1	11553-120C5	19.36	4.59	1.31	2.30	0.66	1.48	0.33	0.82	1.48	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	43.51	14.44	6.62	3.41	2.61	0.80	1.60	3.81	1.80	0.60
Fibroblast - skin normal, donor2	11561-120D4	27.02	5.32	3.32	1.31	0.70	0.60	1.11	1.81	1.71	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	52.59	9.07	4.84	8.46	0.60	0.00	2.12	2.42	0.60	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	33.64	7.37	1.08	2.32	1.41	2.15	0.83	0.41	2.32	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	38.12	3.42	1.54	2.56	1.03	1.03	2.05	1.54	0.85	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	37.11	4.60	3.94	5.91	0.66	0.33	0.66	1.31	0.66	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	30.68	4.05	3.20	1.60	1.38	0.32	0.96	2.13	1.38	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	13.83	3.54	2.53	1.86	0.67	0.67	1.01	0.67	1.01	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	21.01	4.08	0.63	1.41	1.10	0.78	0.31	1.25	1.73	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	221.60	22.16	44.32	0.00	44.32	22.16	22.16	44.32	44.32	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	60.14	6.97	2.61	15.69	2.61	4.36	1.74	0.00	0.87	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	30.16	3.81	0.52	1.56	0.35	0.87	0.69	1.73	1.39	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	31.75	2.60	2.34	2.34	0.78	1.04	0.00	0.52	1.30	0.78
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	34.49	3.58	1.53	2.56	2.04	2.30	0.51	1.02	1.02	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	32.15	5.36	11.48	9.95	2.30	1.53	1.53	0.77	3.83	2.30
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	33.18	4.47	18.50	5.10	1.91	1.91	1.91	0.00	1.91	5.10
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	72.46	7.42	22.25	6.85	1.71	4.85	5.13	3.14	1.43	7.13
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	49.91	6.62	17.92	4.14	1.65	0.28	6.34	1.65	1.38	1.65
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	44.07	5.94	12.79	5.71	1.14	2.28	3.88	1.37	0.91	1.60
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	54.88	3.96	16.44	7.13	1.98	1.78	1.59	1.19	0.99	4.36
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	45.73	5.29	15.60	4.49	0.26	0.79	5.29	0.26	0.79	2.11
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	23.81	7.50	12.07	5.22	1.63	0.33	3.91	1.63	0.33	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	66.78	5.31	25.65	3.54	1.33	5.31	4.42	0.88	1.33	8.84
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	67.98	6.36	32.79	17.52	3.11	3.11	7.35	1.27	0.99	7.49
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	42.11	4.56	15.89	8.62	1.35	1.11	5.54	0.99	0.49	4.31
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	56.68	5.91	24.18	8.60	1.61	3.49	4.57	1.61	1.88	3.22
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	36.80	2.60	5.82	8.18	0.62	0.87	2.85	0.37	0.50	1.61
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	54.54	3.18	12.04	12.46	1.25	1.66	7.48	0.28	0.55	3.05
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	54.08	4.88	13.82	9.56	1.42	1.42	3.05	1.02	1.02	4.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	30.58	1.83	3.88	3.65	1.14	0.91	2.97	1.37	0.23	1.83
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	48.58	3.74	7.35	6.35	1.25	0.50	6.35	0.62	0.37	1.74
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	73.22	6.56	7.43	8.52	2.19	2.84	6.12	0.87	0.22	1.97
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	25.71	3.84	5.91	3.84	1.48	1.18	2.07	0.00	0.30	2.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	40.06	3.66	9.38	7.79	2.54	0.95	5.25	0.48	0.32	1.11
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	46.25	6.48	11.39	6.93	1.56	0.45	4.92	0.67	0.22	1.79
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	24.40	3.02	6.45	4.44	0.20	0.81	2.82	0.20	0.00	1.61
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	33.08	4.75	12.89	7.46	1.36	0.68	5.43	1.02	0.85	3.05
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	57.73	9.04	17.73	8.25	2.31	1.60	6.47	2.75	1.33	3.81
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	42.14	5.41	8.95	6.97	1.46	1.46	5.83	1.35	0.10	3.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	40.13	5.64	8.37	5.12	1.20	0.68	4.10	0.51	0.34	2.56
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	33.97	3.87	6.53	9.29	1.11	1.00	4.65	0.77	0.33	2.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	44.59	7.15	12.31	5.07	2.25	1.41	3.66	1.58	0.58	3.24
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	43.29	4.70	10.62	5.31	1.84	0.20	5.72	2.45	0.61	1.63
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	27.44	4.13	7.63	5.16	1.24	1.24	2.68	0.62	0.41	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	34.13	3.34	6.57	8.65	1.15	0.23	5.19	0.69	0.12	1.27
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	25.85	5.84	6.34	5.84	1.83	0.50	2.17	1.00	0.67	1.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	22.26	4.85	2.65	3.75	0.44	0.22	2.42	0.22	0.44	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	32.22	3.94	6.15	6.15	1.23	0.37	4.67	0.61	0.37	2.34
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	28.69	8.43	6.81	5.19	2.27	0.49	2.11	1.78	0.81	2.11
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	24.70	2.89	4.81	6.74	0.32	0.96	3.53	0.64	0.00	1.60
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	24.73	4.93	4.17	5.87	1.33	0.09	2.84	0.19	0.09	1.04
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	20.88	3.01	3.01	4.90	0.79	0.47	2.53	0.63	0.16	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	27.06	3.04	6.99	5.17	0.61	0.00	2.43	0.91	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	25.30	4.50	4.50	5.96	1.78	0.94	3.87	0.84	0.21	1.25
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	21.74	4.17	4.61	3.07	0.88	0.22	3.51	0.44	0.22	1.10
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	22.72	1.68	5.33	5.61	0.56	0.84	2.81	0.84	0.00	2.24
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	28.15	4.17	2.87	2.69	2.69	0.93	3.70	1.02	0.74	0.46
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	18.72	6.95	4.81	2.14	1.60	0.80	2.94	0.80	0.53	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	21.11	3.06	3.37	3.37	0.92	0.77	1.99	0.92	0.15	1.22
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	19.69	3.76	3.63	2.98	1.04	0.91	2.59	1.30	0.00	1.30
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	20.87	4.34	3.52	4.34	1.36	0.54	2.44	1.36	0.54	1.08
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	16.41	3.69	4.06	3.32	1.11	0.55	2.03	1.29	0.18	0.92
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	21.49	5.48	1.32	2.63	0.88	0.88	2.85	1.97	0.44	1.10
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	25.79	7.93	2.98	4.96	3.97	0.99	1.98	1.98	0.99	2.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	16.88	5.41	3.30	3.03	0.92	0.79	1.45	0.66	0.79	0.66
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	15.33	3.23	2.62	1.41	1.21	0.40	0.61	0.61	0.40	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	33.29	9.40	4.57	2.03	1.78	0.76	8.39	1.02	1.27	2.03
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	106.50	3.98	56.13	12.94	2.19	2.79	11.55	2.79	0.80	16.52
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	61.78	4.01	35.44	14.33	1.08	2.93	10.17	0.77	0.92	7.55
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	73.04	5.73	45.21	14.93	2.66	2.45	6.75	1.43	0.41	6.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	44.44	4.38	16.90	7.51	1.56	1.88	1.25	0.63	0.00	5.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	39.56	2.83	24.86	6.78	2.54	2.54	2.83	0.28	1.41	7.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	112.07	7.38	62.26	25.83	0.46	1.84	5.07	2.31	1.84	9.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	94.04	14.85	61.87	19.80	9.90	2.47	9.90	0.00	4.95	7.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	92.83	10.06	51.06	15.86	6.96	1.93	5.42	1.93	3.48	10.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	75.41	4.81	28.88	14.44	4.81	1.60	4.81	3.21	0.00	6.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	71.29	10.43	36.52	17.39	3.48	1.74	12.17	0.00	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	86.58	12.37	30.92	17.90	3.91	5.53	5.21	1.63	1.63	8.14
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	98.83	10.30	44.47	18.12	4.53	3.71	7.00	1.65	2.06	8.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	106.63	13.33	39.99	10.00	3.33	3.33	16.66	0.00	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	74.11	8.95	33.00	13.98	1.40	4.47	5.03	0.56	1.40	5.87
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	75.17	9.81	25.49	16.02	2.29	2.94	5.56	0.65	0.98	5.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	80.53	8.39	29.36	25.17	0.84	3.36	5.87	0.84	2.52	4.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	77.61	3.18	31.17	11.45	1.27	3.50	6.68	0.32	1.27	6.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	68.27	4.42	30.57	15.28	1.02	2.72	4.42	0.68	1.36	7.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	102.32	2.09	14.62	4.18	0.00	0.00	12.53	0.00	2.09	4.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	68.72	3.44	32.07	10.88	1.15	0.57	4.01	1.15	0.00	6.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	51.80	4.14	14.50	12.43	0.30	0.30	2.07	0.00	0.00	4.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	91.48	11.86	27.11	27.11	3.39	3.39	8.47	1.69	0.00	5.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	75.80	13.25	31.89	15.74	1.24	2.07	3.73	2.07	0.83	5.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	73.18	12.89	29.46	17.03	2.53	2.07	5.98	0.92	2.30	6.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	42.15	5.27	10.54	0.00	5.27	0.00	15.81	0.00	0.00	10.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	49.20	9.61	24.99	13.07	1.54	2.31	4.23	1.15	0.77	5.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	72.69	9.78	21.19	13.69	2.28	0.98	4.89	0.33	0.33	4.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	79.59	4.01	18.73	15.38	3.34	0.67	5.35	0.00	2.01	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	85.53	4.62	25.43	10.79	1.54	0.00	10.02	0.39	0.77	5.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	59.22	11.30	20.20	17.12	3.08	3.08	6.16	1.71	2.05	3.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	131.69	4.97	29.82	22.36	0.00	2.48	9.94	0.00	0.00	7.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	104.28	4.72	19.82	25.01	0.00	1.42	6.13	0.00	0.00	2.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	76.64	6.03	12.67	22.93	0.00	0.60	4.83	0.00	0.60	3.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	91.56	3.05	23.91	17.29	0.51	2.03	6.10	0.51	0.00	5.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	94.13	9.57	27.92	15.55	1.20	1.60	9.57	0.40	0.40	5.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	96.20	3.45	19.73	18.75	0.99	0.49	7.89	0.00	1.48	4.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	113.32	3.54	31.87	23.61	0.00	1.18	7.08	0.00	0.00	7.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	71.18	1.17	16.34	12.84	0.00	0.00	6.42	1.17	0.00	4.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	86.90	4.83	17.99	17.12	0.00	1.32	7.02	0.44	1.32	2.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	56.80	6.78	10.17	11.02	0.00	0.00	9.32	0.00	0.00	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	32.23	3.58	6.57	8.95	0.00	0.60	6.57	1.79	0.60	2.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	47.55	8.73	12.62	10.19	0.97	3.40	5.82	0.97	0.49	3.88
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	5.71	2.28	0.00	0.00	0.00	0.00	0.00	1.14	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	7.90	2.08	0.00	0.83	0.83	0.42	1.66	1.25	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	0.00	2.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	12.37	3.17	0.63	0.63	0.63	0.63	0.32	1.27	0.95	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	8.35	0.42	0.42	0.00	0.42	0.84	0.84	0.42	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	34.58	8.36	4.41	4.53	1.16	1.39	1.04	0.58	0.93	0.93
Hep-2 cells mock treated, biol_rep2	11899-125E9	26.84	8.27	5.91	4.90	0.84	1.35	0.84	0.34	1.52	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	25.71	6.37	5.92	3.41	0.46	2.05	0.23	0.46	1.14	1.82
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	27.44	7.76	4.81	3.61	0.55	2.08	0.77	0.66	1.53	0.87
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	27.94	7.52	4.30	3.22	0.86	1.50	1.50	1.93	0.21	1.07
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	27.34	7.10	5.81	1.94	1.08	1.72	0.65	0.65	0.00	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	32.01	7.35	5.23	3.86	0.50	1.25	0.50	0.75	0.75	0.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	31.57	7.72	7.03	4.46	0.69	1.54	0.69	0.69	0.34	0.69
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	23.39	8.97	4.81	3.52	1.60	1.92	0.96	0.96	0.96	0.96
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	8.95	0.56	0.56	1.12	0.00	0.00	1.12	1.12	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	1.30	0.43	0.00	0.00	0.00	0.00	0.43	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	21.15	2.64	0.00	2.64	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	2.47	1.06	0.71	0.35	0.35	0.00	0.00	0.35	1.06	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	2.18	1.45	0.00	0.00	0.00	0.00	0.00	0.00	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	11.01	2.80	3.32	0.70	1.57	0.35	0.17	0.52	0.35	0.52
Hepatocyte, donor1	11523-119I2	33.90	4.84	1.21	8.47	2.42	0.00	0.00	1.21	0.00	0.00
Hepatocyte, donor2	11603-120I1	34.47	6.46	0.00	9.70	0.00	1.08	1.08	0.00	1.08	0.00
Hepatocyte, donor3	11684-122I1	28.22	8.59	1.23	3.68	1.23	1.84	1.23	1.23	1.23	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	55.48	26.11	53.52	4.57	5.22	1.96	1.31	5.22	1.31	6.53
Intestinal epithelial cells (polarized), donor1	11246-116E4	30.59	15.38	4.19	3.85	0.35	2.10	1.05	0.70	1.92	0.70
Iris Pigment Epithelial Cells, donor1	11530-119I9	22.64	3.84	1.92	1.23	1.37	0.69	0.00	0.69	1.51	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	3.18	0.00	6.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	6.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	8.31	0.00	1.38	2.77	0.00	0.00	0.00	0.00	0.00	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	12.51	0.00	0.00	2.50	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	12.81	0.00	0.00	2.56	0.00	0.00	2.56	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	18.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	8.12	1.62	4.87	3.25	0.00	0.00	0.00	0.00	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	8.34	1.67	1.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	7.26	0.00	0.00	0.00	0.00	0.00	3.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	9.26	1.32	2.65	0.00	0.00	0.00	1.32	0.00	0.00	2.65
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	6.65	0.00	0.00	2.22	0.00	0.00	0.00	0.00	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	20.95	0.00	0.00	10.48	0.00	5.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	8.82	0.00	1.26	5.67	0.00	0.00	0.63	0.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	3.09	0.00	1.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	6.46	0.65	1.94	3.88	0.65	0.65	0.65	0.00	0.00	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	4.83	3.22	0.00	3.22	0.00	0.00	0.00	0.00	0.00	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	17.11	0.00	2.44	3.26	0.00	0.81	0.00	0.00	0.00	1.63
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	4.20	0.42	0.84	1.26	0.00	0.00	0.42	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	6.43	0.00	2.41	2.41	0.00	0.00	0.00	0.00	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	4.62	0.92	0.92	0.92	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	2.36	0.00	0.94	1.89	0.00	0.00	0.47	0.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	2.72	0.91	2.72	1.81	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	14.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	6.46	0.00	1.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	2.54	1.27	3.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	16.43	0.00	0.00	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	6.38	0.64	0.64	2.55	0.64	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	1.82	0.00	1.82	0.00	0.00	0.00	0.00	0.00	1.82	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	6.43	0.71	0.71	3.57	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	6.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	6.17	1.54	1.23	1.54	0.00	0.00	0.62	0.00	0.00	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	1.76	1.76	0.00	1.76	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	15.72	0.00	6.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	7.65	0.70	2.78	2.09	0.70	0.00	0.00	0.70	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	8.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	9.73	0.00	0.00	3.24	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	13.08	0.87	2.62	1.74	0.87	0.00	0.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	13.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	6.97	0.00	3.48	3.48	0.00	0.00	0.00	0.00	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	7.47	0.00	1.07	0.00	0.00	0.00	0.00	0.00	0.00	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	8.31	0.00	0.00	2.77	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	8.55	0.00	0.00	2.85	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	4.60	0.00	1.84	0.00	0.00	0.00	0.00	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	3.03	0.00	0.00	3.03	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	9.52	0.00	0.00	2.11	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	20.48	2.45	0.33	1.47	0.41	0.57	0.57	0.49	0.57	0.08
Keratinocyte - epidermal, donor2	11349-117G8	4.10	0.00	0.59	0.00	0.00	0.00	0.59	0.00	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	22.24	3.22	1.80	1.61	0.28	0.19	0.47	0.38	0.28	0.28
Keratinocyte - oral, donor1	11251-116E9	71.52	2.95	2.61	3.75	0.34	2.38	1.36	0.57	1.36	0.34
Keratocytes, donor1	11527-119I6	7.91	2.06	1.03	1.72	0.34	0.00	0.34	0.34	0.00	0.00
Keratocytes, donor2	11607-120I5	8.20	0.00	1.17	1.17	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	24.50	4.15	0.20	6.13	0.59	0.20	0.99	0.40	0.00	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	17.58	6.59	2.20	15.39	2.20	8.79	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	12.94	4.31	2.16	2.16	0.00	0.00	0.00	0.00	1.08	1.08
Lens Epithelial Cells, donor2	11609-120I7	34.71	2.19	3.58	2.31	1.61	1.04	2.08	0.69	0.46	1.27
Lens Epithelial Cells, donor3	11690-122I7	18.37	3.23	0.30	1.31	2.02	1.21	0.61	1.61	1.51	0.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	8.89	2.49	0.59	0.95	1.07	0.36	0.24	0.95	0.12	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	6.14	1.12	0.56	0.28	0.56	0.00	0.00	0.84	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	14.64	6.30	0.79	0.31	2.68	0.31	0.31	2.68	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	5.91	3.23	0.54	0.54	0.00	0.00	1.08	0.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	3.78	2.21	0.32	0.00	0.32	0.00	0.00	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	3.88	1.73	0.32	0.32	0.65	0.00	0.00	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	9.44	4.51	0.41	1.23	1.64	0.00	0.41	0.41	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	3.03	1.01	0.00	0.00	0.00	0.00	0.00	0.76	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	5.07	1.97	0.42	0.56	0.84	0.14	0.28	0.84	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	3.56	3.96	0.00	0.40	2.37	0.00	0.00	0.79	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	7.95	2.33	0.00	0.39	0.19	0.00	0.39	0.78	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	2.59	1.48	0.37	0.00	0.93	0.19	0.00	0.74	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	8.71	3.48	1.05	1.05	0.00	0.00	0.00	0.35	0.00	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	6.68	0.95	0.00	0.24	0.24	0.00	0.00	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	2.75	1.24	0.41	0.14	0.14	0.14	0.14	0.69	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	12.63	3.70	0.62	0.62	1.85	0.00	0.00	1.85	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	2.49	0.62	0.00	0.31	0.31	0.31	0.00	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	4.39	2.20	0.00	0.18	0.91	0.00	0.18	0.91	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	7.57	1.32	0.99	0.33	0.66	0.00	0.00	0.66	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	3.51	1.17	0.29	0.59	0.59	0.00	0.29	0.88	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	2.74	1.49	0.75	0.75	0.25	0.00	0.00	0.25	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	6.30	1.45	0.00	0.48	4.36	0.00	0.00	1.45	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	5.92	2.15	0.54	1.08	1.35	0.27	0.00	1.08	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	6.81	2.12	0.30	0.45	1.82	0.61	0.00	0.30	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	4.15	2.07	0.52	0.00	0.52	0.00	0.00	1.04	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	8.79	4.61	1.05	0.21	0.42	0.00	0.42	1.05	0.63	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	4.51	2.11	0.15	0.15	0.75	0.15	0.15	0.15	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	11.01	2.75	0.00	0.00	2.06	0.00	0.69	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	5.46	2.82	0.75	0.56	1.13	0.00	0.19	0.75	0.19	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	1.91	0.64	0.21	0.21	1.17	0.21	0.21	0.42	0.00	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	4.85	3.39	0.48	1.94	0.97	0.00	0.00	1.45	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	4.96	1.32	0.66	0.00	1.32	0.00	0.33	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	2.73	0.50	0.12	0.25	0.50	0.12	0.12	0.12	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	16.66	7.03	0.37	0.74	1.85	0.37	0.37	1.85	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	6.42	2.22	0.49	0.25	0.49	0.00	0.49	0.99	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	2.20	1.10	0.00	0.14	0.27	0.55	0.00	0.41	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	11.90	5.15	0.00	0.32	0.64	0.00	0.32	0.64	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	10.04	3.65	0.91	1.22	1.83	0.61	0.00	1.83	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	8.68	4.20	0.42	0.42	1.54	0.56	0.14	0.98	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	8.89	6.04	1.07	0.36	0.36	0.00	0.00	2.13	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	3.39	0.97	0.48	0.48	0.48	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	1.24	0.93	0.16	0.00	0.31	0.00	0.00	0.62	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	6.09	2.86	1.07	1.43	1.79	0.00	0.36	0.72	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	5.55	1.63	0.33	0.33	0.98	0.00	0.00	0.00	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	2.83	0.94	0.24	0.24	0.24	0.00	0.24	0.00	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	9.03	2.97	0.74	0.87	1.61	0.12	0.12	0.87	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	1.54	0.77	0.00	0.26	0.00	0.00	0.00	0.51	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	3.88	2.09	0.60	0.90	1.49	0.00	0.30	0.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	11.33	6.80	0.00	0.00	0.00	2.27	0.00	0.00	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	17.64	1.53	0.77	5.37	0.00	1.53	0.00	0.00	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	16.33	1.48	0.74	2.23	0.00	0.74	0.00	0.00	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	8.89	2.12	1.69	3.39	0.42	1.69	1.69	0.42	0.85	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	7.74	5.63	0.70	3.52	0.00	0.00	0.70	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	14.94	0.00	1.87	4.67	0.00	1.87	1.87	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	10.31	1.03	1.03	2.58	0.00	1.03	0.00	0.52	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	9.52	2.38	0.00	4.76	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	10.63	3.17	1.36	1.81	0.00	1.36	0.45	0.23	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	19.49	4.65	1.74	4.07	0.29	2.62	1.74	0.29	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	23.86	4.05	2.25	4.05	0.45	1.35	0.90	1.80	1.80	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	15.58	4.06	0.95	2.85	0.41	1.76	0.54	0.41	0.68	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	9.76	2.57	1.03	4.62	0.00	0.00	0.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	20.82	4.94	1.76	6.00	0.71	1.41	0.00	0.71	0.71	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	16.66	3.33	0.67	2.67	0.67	0.67	0.67	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	11.72	3.57	1.53	5.60	0.51	0.51	0.51	0.00	1.53	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	19.21	5.07	1.60	4.00	0.53	2.13	0.27	1.07	1.60	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	18.33	5.29	1.89	5.29	0.76	0.94	0.94	0.57	2.08	0.94
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	12.27	3.68	1.23	1.84	0.00	0.61	0.61	0.00	0.61	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	17.94	4.08	3.26	6.52	2.45	0.00	0.00	0.00	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	24.99	2.50	2.71	6.87	0.42	2.08	1.25	1.25	2.29	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	21.58	5.04	2.80	6.45	0.00	2.80	1.12	0.56	1.96	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	20.61	2.06	2.06	2.06	1.03	1.03	0.00	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	20.90	6.10	1.45	5.23	0.29	2.03	1.74	0.29	1.16	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	16.74	3.89	1.49	3.59	0.00	2.09	0.90	0.60	1.20	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	18.81	3.87	2.21	5.53	0.00	0.55	0.00	0.00	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	19.44	2.47	2.47	5.66	0.71	0.35	1.06	0.00	1.41	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	14.01	4.43	2.21	6.27	0.37	1.11	0.74	0.00	2.21	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	12.66	1.15	0.00	8.06	1.15	0.00	0.00	0.00	2.30	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	14.20	2.69	1.15	5.76	0.38	1.15	0.38	0.00	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	13.02	3.96	0.57	5.66	0.00	1.70	0.00	0.00	1.13	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	13.95	0.00	0.00	3.28	0.00	0.00	0.82	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	9.94	1.81	0.90	4.97	0.00	0.00	0.00	0.00	1.36	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	12.21	1.44	0.72	7.18	0.00	0.72	0.72	0.00	0.00	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	20.17	3.73	3.73	2.99	0.00	2.24	0.00	0.00	2.24	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	12.26	2.97	1.11	3.72	0.00	0.74	0.37	0.00	0.74	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	19.38	1.72	1.72	6.46	0.00	0.86	0.43	0.43	0.43	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	13.70	2.57	1.71	6.85	0.00	2.57	0.00	0.00	2.57	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	14.66	4.66	1.00	5.00	0.00	0.33	0.33	0.00	1.00	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	13.88	0.60	1.81	4.22	0.00	1.81	0.60	0.60	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	19.91	4.98	0.00	2.84	0.71	3.55	0.71	1.42	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	17.19	4.12	1.72	3.78	0.00	1.72	0.69	0.34	0.34	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	12.88	2.15	1.07	3.22	0.00	0.54	0.00	0.54	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	13.47	0.67	0.67	4.04	0.00	0.67	0.00	0.00	1.35	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	14.08	2.59	1.11	7.41	1.11	0.74	0.74	0.00	0.74	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	20.93	2.33	2.33	0.00	1.16	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	10.58	1.06	0.00	1.06	0.00	0.00	0.00	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	21.61	2.80	2.40	7.20	0.00	2.40	0.40	0.40	1.20	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	8.72	0.73	2.91	2.18	0.73	0.00	1.45	0.00	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	16.10	3.07	1.53	1.53	0.00	1.53	0.77	0.77	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	14.80	3.45	1.97	3.95	0.00	0.99	0.49	0.99	0.99	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	9.41	3.76	0.94	3.76	0.00	0.00	0.94	1.88	0.00	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	12.57	3.52	2.51	2.51	0.50	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	12.17	3.15	2.25	5.41	0.00	3.15	0.45	0.45	0.90	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	5.16	0.00	1.72	3.44	0.00	0.00	1.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	9.80	3.56	0.89	3.12	0.00	0.45	0.89	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	14.86	2.35	0.39	3.13	0.00	0.78	0.78	0.39	0.00	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	9.24	2.64	0.66	2.64	0.00	1.32	0.66	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	16.61	1.56	0.52	6.23	0.00	0.00	0.52	0.52	2.08	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	12.69	3.50	0.88	2.19	0.88	1.75	0.88	0.44	2.19	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	17.33	5.03	2.24	3.35	0.56	0.56	0.56	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	14.13	4.86	1.32	4.86	0.44	1.77	0.44	0.88	1.32	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	15.81	1.93	1.93	5.40	0.39	1.93	0.77	0.77	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	13.17	2.53	2.03	2.53	0.00	0.51	0.51	0.00	1.01	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	12.98	1.92	0.96	3.84	0.00	0.00	1.44	0.48	1.92	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	13.91	4.37	2.39	8.35	0.40	1.19	1.19	0.80	1.59	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	13.98	2.43	0.00	3.65	0.00	0.61	0.61	0.61	1.82	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	11.76	2.77	1.38	3.46	0.00	0.00	2.08	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	16.72	2.28	2.28	3.80	0.00	0.76	0.38	0.00	0.76	1.14
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	11.36	3.61	2.58	3.61	0.00	0.52	0.00	0.00	0.52	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	8.47	1.21	1.21	0.60	0.00	0.00	1.81	1.81	0.60	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	19.01	4.12	1.58	6.65	0.00	1.58	0.95	0.63	1.58	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	9.06	2.13	0.00	2.67	0.00	1.60	1.07	0.53	0.53	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	9.19	2.30	2.30	1.72	0.00	0.57	0.57	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	9.77	1.03	1.54	6.69	0.00	1.54	0.00	0.51	1.03	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	7.78	0.00	0.00	2.83	0.00	1.41	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	8.51	0.57	1.70	3.40	0.00	0.57	1.70	0.00	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	11.65	2.91	1.66	5.82	0.00	2.08	0.83	0.00	1.25	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	8.61	4.70	0.78	2.35	0.00	0.78	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	9.19	2.51	0.84	3.76	0.00	0.84	1.25	0.42	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	10.22	2.79	1.39	2.79	0.00	1.86	0.93	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	7.36	0.67	0.67	0.00	0.00	0.00	0.67	0.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	10.69	1.60	1.07	4.28	0.00	0.00	0.00	0.53	1.07	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	8.08	0.81	1.21	2.02	0.40	0.40	0.00	0.00	0.00	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	7.34	0.92	0.92	2.75	0.92	2.75	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	16.89	1.78	0.00	2.67	0.00	1.78	0.00	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	13.11	5.13	2.28	3.42	0.00	1.71	0.00	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	7.67	0.00	0.77	1.53	0.77	0.00	0.00	1.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	11.49	1.09	0.55	5.47	0.55	0.00	0.55	0.00	1.09	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	7.13	0.89	0.45	2.23	0.00	0.45	0.45	0.45	0.45	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	11.18	0.78	1.04	3.12	0.00	0.52	0.00	0.00	0.52	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	11.94	1.99	0.66	2.65	0.00	1.33	0.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	10.39	0.00	2.08	4.16	0.00	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	23.25	9.12	0.46	1.14	3.65	0.46	2.73	1.37	0.68	0.00
Macrophage - monocyte derived, donor2	11313-117C8	15.05	2.02	0.55	1.47	1.10	0.73	2.75	0.73	1.47	0.00
Macrophage - monocyte derived, donor3	11389-118C3	16.78	4.72	0.52	1.44	1.44	0.39	2.10	1.18	0.52	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	14.87	1.06	1.06	0.00	0.00	1.06	0.00	0.53	1.59	0.00
Mallassez-derived cells, donor2	11929-125I3	27.89	5.86	0.79	1.74	1.27	2.38	0.48	0.00	1.58	0.00
Mallassez-derived cells, donor3	11930-125I4	36.14	5.98	1.25	1.25	0.56	1.53	0.56	1.53	1.39	0.14
Mammary Epithelial Cell, donor1	11273-116H4	71.34	10.36	4.19	4.78	2.09	0.70	1.79	1.40	1.10	1.20
Mammary Epithelial Cell, donor2	11350-117G9	48.93	5.21	4.92	4.92	2.32	0.29	0.87	0.29	1.74	0.29
Mammary Epithelial Cell, donor3	11422-118F9	8.23	2.00	0.50	0.75	0.00	0.50	0.00	0.25	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	178.30	56.95	8.14	0.68	28.47	11.52	21.69	14.24	6.78	3.39
Mast cell, donor1	11563-120D6	55.26	6.81	3.68	2.16	6.81	4.87	6.38	3.57	2.05	0.54
Mast cell, donor2	11565-120D8	104.01	19.91	2.08	4.46	13.08	3.27	18.42	9.81	1.19	0.30
Mast cell, donor3	11566-120D9	115.71	21.84	2.48	2.25	17.56	2.48	19.59	9.68	1.58	1.58
Mast cell, donor4	11567-120E1	102.12	19.50	2.66	2.13	12.23	3.37	16.49	7.80	0.89	1.06
Mast cell, expanded and stimulated, donor5	11940-126A5	58.66	11.87	3.99	3.11	3.99	5.21	4.10	2.88	2.22	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	42.03	8.17	4.09	3.50	2.33	1.17	2.92	1.17	1.75	0.58
Mast cell, expanded, donor5	11939-126A4	44.05	8.03	2.18	1.61	1.72	3.10	5.05	2.29	1.49	0.57
Mast cell, expanded, donor8	11941-126A6	64.94	13.05	6.53	3.85	8.20	3.85	6.53	5.19	1.51	0.33
Melanocyte - dark, donor1	11502-119F8	27.66	7.76	1.69	1.29	4.28	0.70	0.10	2.09	0.99	0.30
Melanocyte - dark, donor2	11582-120F7	15.92	4.50	1.38	2.77	0.69	0.00	0.69	0.35	0.69	0.35
Melanocyte - dark, donor3	11663-122F7	32.60	4.06	7.90	1.45	1.74	0.36	3.69	1.38	0.43	1.74
Melanocyte - light, donor1	11274-116H5	5.88	0.94	0.47	0.47	0.00	0.47	0.71	0.24	0.00	0.00
Melanocyte - light, donor2	11351-117H1	2.05	1.36	0.68	1.36	0.68	0.00	0.68	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	8.67	0.87	0.00	2.60	0.00	1.73	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	22.80	4.27	1.98	3.02	0.73	0.31	2.08	0.83	0.31	0.31
Melanocyte, donor2 (MC+2)	12739-135I3	14.25	6.45	2.15	2.42	1.34	0.81	1.88	1.34	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	15.54	8.30	1.07	2.95	1.07	1.07	2.14	1.61	0.80	0.27
Meningeal Cells, donor1	11493-119E8	16.00	0.62	2.36	1.49	1.36	0.25	0.25	0.74	0.12	0.62
Meningeal Cells, donor2	11573-120E7	6.60	0.00	0.44	0.88	0.44	0.00	0.00	1.32	0.00	0.00
Meningeal Cells, donor3	11654-122E7	34.15	9.54	8.97	2.45	7.74	0.65	1.14	4.08	0.90	1.39
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	27.66	4.56	4.56	0.00	1.43	2.00	0.57	0.57	0.86	0.86
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	17.91	3.82	0.00	2.82	0.70	0.91	0.20	0.50	0.81	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	1.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	5.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	21.53	2.15	2.87	0.00	1.44	0.00	1.44	0.00	0.72	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	16.09	2.96	0.64	1.06	0.85	0.00	0.64	0.85	0.64	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	12.57	2.51	0.50	1.01	0.50	0.00	0.00	0.50	1.01	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	5.93	1.10	2.20	0.88	0.44	0.00	0.22	0.22	0.22	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	3.65	1.46	2.19	0.00	0.73	0.00	0.73	0.00	0.73	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	3.48	0.41	0.41	0.82	0.20	0.00	0.20	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	30.89	0.97	0.83	1.25	0.28	0.28	2.22	0.14	0.28	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	5.20	0.00	0.37	0.37	0.00	0.00	0.00	0.00	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	38.29	6.18	1.32	1.71	0.39	1.05	2.37	0.79	1.18	0.39
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	7.12	0.59	0.00	0.00	0.30	0.00	0.30	0.30	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	9.34	2.34	2.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	3.84	0.64	0.00	0.64	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	26.23	3.90	4.61	0.35	1.77	1.42	1.06	1.77	0.71	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	33.46	5.00	1.88	0.31	0.63	0.31	0.94	1.25	0.94	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	9.43	0.73	2.18	0.00	0.73	0.00	1.45	0.73	0.73	0.73
Mesothelial Cells, donor1	11247-116E5	14.32	3.18	0.27	0.80	1.06	1.59	0.00	1.06	2.12	0.27
Mesothelial Cells, donor2	12156-128G5	4.50	2.00	0.50	0.00	1.00	0.50	0.00	0.00	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	8.74	3.04	0.65	0.87	0.58	0.72	0.65	0.43	2.60	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	13.50	8.10	0.00	0.00	1.35	0.00	2.70	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	24.13	6.90	0.25	0.74	0.99	0.49	3.45	0.74	0.74	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	12.96	3.24	0.59	2.65	0.00	0.00	0.88	0.59	0.88	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	3.46	0.00	0.00	0.00	0.00	0.00	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	17.36	5.89	0.93	0.93	1.86	0.00	3.41	0.62	0.31	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	9.96	2.90	0.62	1.24	1.24	0.41	0.83	0.83	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	6.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	16.27	4.00	0.25	0.25	2.00	0.50	3.00	2.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	8.84	4.65	0.00	0.93	2.33	0.47	1.86	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	17.68	5.08	0.20	0.61	1.02	0.20	1.63	0.61	0.20	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	10.30	2.77	1.19	1.19	2.38	0.40	1.19	1.19	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	11.50	2.65	0.00	0.88	1.77	0.00	2.65	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	9.50	4.56	0.38	0.76	1.14	0.38	2.66	0.76	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	1.32	7.90	0.00	0.00	0.00	0.00	0.00	2.63	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	17.40	4.88	0.00	1.06	2.76	0.21	0.85	2.33	0.21	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	2.76	2.76	0.00	0.00	3.68	0.00	0.92	1.84	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	11.62	4.17	0.00	0.60	5.07	0.60	2.09	2.09	0.00	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	8.38	5.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	14.05	6.27	0.75	1.76	5.27	0.00	2.01	1.51	0.75	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	9.98	4.04	0.48	1.19	3.57	0.48	0.71	1.43	0.48	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	2.76	6.63	1.66	0.00	4.42	1.11	0.55	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	10.36	8.06	0.23	0.46	6.91	0.23	1.84	1.84	0.23	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	8.41	4.21	0.21	0.42	2.73	0.21	1.47	1.47	1.26	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	11.82	7.54	0.20	1.02	6.73	0.61	1.63	3.87	0.41	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	15.45	9.23	0.43	1.07	4.51	0.00	1.50	1.93	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	5.11	6.00	0.67	1.56	2.89	0.00	1.33	2.22	0.89	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	10.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	11.39	9.64	0.44	0.88	6.13	0.00	1.10	2.85	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	4.56	5.58	0.00	0.51	2.53	0.00	0.00	2.03	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	4.97	11.60	0.00	1.66	4.97	0.00	3.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	11.96	14.68	0.54	0.54	14.40	0.00	1.63	4.89	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	7.35	8.23	0.00	0.59	5.29	0.00	1.76	1.47	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	3.27	9.81	0.00	0.00	3.27	0.00	1.09	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	8.65	7.69	0.00	0.48	3.84	0.00	1.92	2.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	8.00	6.40	1.20	1.20	4.00	0.00	1.20	2.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	2.74	10.97	0.00	0.00	12.34	0.00	0.00	4.11	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	6.51	8.51	0.50	0.50	4.51	0.00	0.00	2.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4.08	8.15	0.00	0.00	4.08	0.00	0.00	4.08	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	13.14	9.20	0.88	1.31	8.32	0.00	0.88	3.50	0.44	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	6.62	4.41	0.00	1.10	4.41	0.00	0.00	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	8.97	12.17	0.64	0.00	7.04	0.00	0.64	3.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	14.63	15.12	0.99	0.99	5.45	0.50	0.50	3.22	0.25	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	4.87	3.48	0.00	0.00	2.78	0.00	0.70	0.00	1.39	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	0.00	11.05	0.00	0.00	8.84	0.00	0.00	6.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	12.31	10.60	1.71	1.03	5.47	0.34	2.05	1.37	0.68	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	7.00	4.38	0.44	1.75	1.31	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	9.23	8.17	0.36	1.07	10.65	0.00	1.78	2.49	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	13.19	6.45	0.56	1.12	10.10	0.28	1.12	3.37	0.00	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	7.07	5.40	0.42	0.42	2.49	0.00	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	5.83	6.41	1.17	0.00	2.91	0.00	0.58	2.91	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	7.84	13.88	0.30	0.90	4.52	0.00	1.21	2.71	0.00	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	10.85	5.43	0.83	1.25	2.92	0.00	0.83	1.67	0.00	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00	7.22	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	8.31	11.08	0.92	0.00	10.16	0.00	2.77	5.54	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	9.68	6.26	1.71	0.57	1.71	0.00	1.14	1.71	1.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	15.61	8.71	0.41	1.52	5.67	0.00	0.97	2.21	0.14	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	12.96	8.03	0.52	0.26	3.11	0.00	0.52	3.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	13.30	11.58	0.86	0.86	3.86	0.43	0.43	4.29	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	6.35	6.35	0.00	0.00	5.08	0.00	1.27	2.54	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	11.74	14.41	0.80	0.27	7.47	0.00	1.87	3.20	0.27	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	21.25	6.88	0.30	0.90	3.29	0.00	1.50	3.59	0.60	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	11.44	7.63	0.28	0.71	5.09	0.14	1.27	2.97	0.28	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	9.56	8.60	0.96	0.64	5.73	0.00	0.64	2.23	0.32	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	15.26	5.75	0.66	0.88	1.77	0.22	0.44	0.88	0.88	0.66
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	11.38	12.51	0.38	0.38	5.69	0.00	0.00	3.03	0.38	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	16.76	18.47	0.85	1.14	7.67	0.00	1.14	4.26	0.57	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	11.06	7.37	0.49	0.49	3.20	0.00	0.74	2.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	9.78	7.17	0.00	0.00	5.21	0.00	0.00	1.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	11.17	15.29	1.18	0.88	7.64	0.00	1.18	2.06	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	14.42	13.84	0.58	1.44	2.31	0.00	2.59	2.59	0.58	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	22.26	11.13	0.41	0.41	5.36	0.00	1.65	4.95	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	15.48	11.61	0.60	0.89	8.93	0.00	0.60	3.57	0.60	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	11.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	16.04	3.56	3.56	0.00	1.78	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	13.47	5.91	0.33	2.30	2.30	0.33	1.64	0.99	0.33	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	8.42	5.26	1.05	0.00	1.05	0.00	4.21	2.10	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	19.57	7.31	0.40	0.59	0.79	0.79	5.14	0.40	0.79	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	24.21	7.45	0.93	1.86	2.79	0.93	3.73	0.93	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	17.65	2.25	0.38	0.75	0.75	0.00	2.63	0.75	1.50	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	10.12	2.13	0.00	1.60	1.07	0.53	2.66	0.00	0.80	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	17.19	6.90	0.45	0.23	2.15	0.23	2.94	1.13	0.45	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	10.31	2.95	0.74	0.74	0.00	0.00	0.74	0.74	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	12.46	5.50	0.00	1.10	2.20	0.37	2.93	0.73	1.10	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	6.22	4.67	0.00	1.56	1.56	1.56	3.11	3.11	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	17.10	9.62	0.53	0.53	0.00	0.00	2.14	2.14	1.07	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	10.10	2.02	1.01	1.01	1.01	0.00	2.02	0.00	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	15.60	7.17	0.42	0.84	1.69	0.42	2.53	0.00	1.26	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	14.98	9.53	0.00	1.36	12.26	0.00	4.09	1.36	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	3.81	7.63	0.64	0.64	4.45	0.00	1.91	0.64	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	5.67	0.81	0.00	0.00	3.24	0.00	4.05	3.24	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	10.57	1.51	0.00	1.51	4.53	0.00	3.02	0.00	1.51	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	34.26	79.94	0.00	0.00	17.13	0.00	22.84	11.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	29.36	42.41	16.31	0.00	26.10	0.00	29.36	19.57	3.26	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	23.76	9.50	4.75	0.00	23.76	0.00	14.26	9.50	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	50.20	0.00	0.00	12.55	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	22.19	4.09	0.86	0.65	1.29	0.43	0.86	1.72	0.43	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	25.61	4.70	0.52	2.61	2.09	1.57	1.05	0.52	1.05	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	11.35	2.00	0.67	7.34	0.00	0.67	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	10.85	0.83	0.42	2.92	0.83	0.00	1.25	0.42	1.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	37.27	11.41	4.37	7.23	2.66	1.71	1.33	2.66	0.76	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	59.05	15.96	4.79	0.00	0.00	1.60	1.60	0.00	1.60	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	10.88	1.36	0.00	2.72	1.36	0.68	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	79.02	29.40	5.51	16.54	0.00	1.84	1.84	9.19	11.03	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	11.30	0.42	0.84	6.28	0.42	0.42	0.42	0.42	0.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	18.36	2.79	0.70	2.79	0.46	0.46	0.46	1.16	0.46	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	17.02	2.97	0.00	6.22	0.00	1.08	0.81	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	24.39	3.99	0.21	4.41	0.84	0.63	0.42	0.84	0.84	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	122.48	77.94	0.00	100.21	33.40	11.13	11.13	11.13	44.54	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	15.88	1.99	0.00	2.48	0.00	0.00	0.00	0.00	1.49	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	18.95	4.06	0.27	3.25	0.54	0.81	1.08	0.81	0.27	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	18.59	1.59	0.23	2.95	0.23	0.68	0.68	0.00	0.68	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	15.35	1.63	0.82	4.90	0.16	0.49	0.65	0.00	0.16	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	28.61	4.74	1.46	4.01	0.73	0.91	1.46	0.55	0.55	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	14.85	0.53	0.53	3.18	0.00	0.00	1.06	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	10.21	0.00	0.00	3.00	0.00	0.60	0.60	0.00	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	42.99	15.75	1.31	3.94	3.28	3.94	0.98	2.63	4.59	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	13.50	1.14	0.00	3.42	0.16	0.33	0.65	0.33	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	32.28	6.35	1.41	7.06	0.88	0.53	1.76	0.88	0.53	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	14.77	1.41	0.00	2.11	0.70	0.00	0.70	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	21.61	2.30	1.38	1.84	0.00	0.46	1.38	0.92	0.92	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	25.39	1.61	0.00	5.78	0.32	0.32	1.61	0.00	0.64	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	38.97	7.93	1.38	2.07	2.07	2.41	2.41	1.03	4.48	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	70.80	37.93	2.53	70.80	5.06	7.59	7.59	12.64	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	18.71	5.12	0.67	4.01	0.67	0.89	2.23	0.89	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	14.40	3.39	0.85	3.39	1.27	0.42	1.27	0.00	0.85	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	18.99	3.80	0.24	4.03	0.71	0.71	2.61	0.71	0.95	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	14.17	0.86	0.43	5.15	0.00	0.00	0.86	0.43	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	117.36	36.11	0.00	189.58	9.03	18.06	9.03	9.03	27.08	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	16.99	2.33	0.00	3.33	0.00	0.00	1.00	0.00	0.67	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	14.88	1.35	0.45	2.25	0.45	0.45	0.45	0.00	0.45	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	11.11	1.59	0.00	3.97	0.00	0.00	0.79	0.40	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	26.93	1.86	0.00	3.71	0.00	0.00	0.93	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	20.43	3.41	0.00	3.78	0.00	0.76	0.00	0.38	1.14	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	11.41	0.98	0.33	6.19	0.65	0.33	0.00	0.33	0.65	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	12.20	2.61	0.44	6.10	0.00	0.00	0.44	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	16.73	5.43	0.45	5.88	0.90	0.45	0.45	0.00	0.90	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	19.40	0.88	0.00	2.65	0.00	0.88	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	18.62	3.99	1.33	5.32	0.00	0.66	0.00	0.00	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	28.27	1.49	0.50	5.46	0.50	0.00	0.99	0.00	0.50	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	8.42	0.77	0.00	5.36	0.00	0.77	0.38	0.00	0.38	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	33.87	3.33	0.00	3.63	0.00	0.91	1.21	0.30	0.00	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	18.12	5.75	0.44	5.75	0.88	0.66	0.22	0.66	0.22	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	8.81	0.68	0.00	2.03	0.00	0.00	0.00	0.00	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	66.42	40.88	0.00	45.99	20.44	10.22	15.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	24.39	1.83	0.00	4.88	0.61	0.61	0.61	0.00	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	10.70	0.31	0.00	2.52	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	12.71	1.21	0.00	12.11	0.00	0.00	0.30	0.00	0.61	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	17.41	0.79	0.00	4.75	0.00	2.37	0.79	0.79	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	22.67	7.94	2.27	5.67	1.13	0.00	2.27	4.53	3.40	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	75.87	30.35	5.06	91.04	15.17	10.12	20.23	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	12.17	6.09	0.75	0.62	0.87	0.87	0.25	0.62	1.37	0.25
Myoblast, donor2	11322-117D8	21.10	8.82	0.96	2.11	0.96	0.96	1.15	1.15	1.73	0.19
Myoblast, donor3	11398-118D3	21.52	6.22	1.01	0.50	2.02	1.51	0.17	1.85	1.35	0.50
NK T cell leukemia cell line:KHYG-1	10777-110G3	23.35	10.07	9.19	5.55	2.33	2.33	0.15	1.61	0.58	2.33
Natural Killer Cells, donor1	11230-116C6	26.75	21.83	2.77	5.54	41.82	5.54	0.00	9.23	4.00	2.46
Natural Killer Cells, donor2	11311-117C6	9.65	23.22	3.62	7.54	28.04	3.92	0.30	5.13	1.51	0.30
Natural Killer Cells, donor3	11387-118C1	15.64	20.80	2.76	3.68	31.47	3.68	0.00	5.71	0.92	0.55
Neural stem cells, donor1	11275-116H6	62.06	28.31	16.70	7.98	7.62	3.27	2.18	2.90	7.26	2.18
Neural stem cells, donor2	11352-117H2	53.92	19.26	7.70	5.78	3.85	3.85	1.93	9.63	0.00	3.85
Neurons, donor1	11494-119E9	17.07	12.52	7.97	7.97	1.14	0.00	0.00	0.00	1.14	0.00
Neurons, donor2	11574-120E8	22.68	9.69	3.30	3.30	2.64	2.42	1.32	1.54	0.88	0.66
Neurons, donor3	11655-122E8	14.80	9.04	2.47	4.93	0.82	1.64	0.00	1.64	4.93	0.82
Neutrophils, donor1	11233-116C9	254.27	25.06	0.00	1.86	40.83	7.42	12.06	3.71	0.93	0.00
Neutrophils, donor2	11314-117C9	165.24	8.70	2.90	0.00	14.49	2.90	8.70	5.80	2.90	0.00
Neutrophils, donor3	11390-118C4	448.36	21.99	1.83	4.89	39.09	7.94	20.77	11.00	2.44	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	47.85	10.80	1.07	2.61	0.83	3.44	1.90	1.66	1.54	0.71
Nucleus Pulposus Cell, donor2	11409-118E5	13.02	1.63	0.33	1.30	0.00	0.33	0.65	0.00	1.30	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	24.67	1.20	0.80	1.00	0.20	0.20	0.60	0.60	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	19.41	5.51	0.41	1.10	0.55	1.10	0.28	0.55	1.79	0.14
Olfactory epithelial cells, donor2	11934-125I8	19.25	5.50	0.43	1.88	0.43	0.87	0.14	0.43	2.03	0.29
Olfactory epithelial cells, donor3	11935-125I9	16.46	3.06	0.23	1.93	0.34	1.48	0.34	0.45	1.48	0.11
Olfactory epithelial cells, donor4	11936-126A1	25.91	4.09	0.88	2.73	0.39	1.56	0.29	0.10	0.58	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	33.10	4.81	1.81	4.21	0.00	1.20	0.00	0.60	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	11.91	0.64	0.21	0.85	0.00	0.21	1.49	0.00	0.00	0.43
Osteoblast - differentiated, donor2	11353-117H3	2.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	5.59	1.86	0.62	0.62	1.24	0.62	0.00	0.62	0.00	0.00
Osteoblast, donor1	11277-116H8	2.35	0.00	0.00	0.78	0.39	0.00	0.39	0.00	0.00	0.00
Osteoblast, donor2	11354-117H4	19.66	2.81	4.21	2.11	0.70	0.70	0.70	3.51	2.11	0.00
Osteoblast, donor3	11426-118G4	9.42	2.67	1.24	1.42	0.36	0.00	0.18	0.36	0.53	0.18
Pancreatic stromal cells, donor1	11249-116E7	36.14	5.81	2.36	1.43	0.84	1.10	1.68	1.01	1.52	0.42
Pericytes, donor1	11491-119E6	3.00	0.56	0.11	0.33	0.22	0.00	0.33	0.11	0.11	0.00
Pericytes, donor2	11571-120E5	3.40	0.45	0.00	1.36	0.23	0.00	0.45	0.23	0.00	0.00
Pericytes, donor3	11652-122E5	4.07	0.81	0.00	0.41	0.41	0.00	0.00	0.20	0.00	0.41
Perineurial Cells, donor1	11499-119F5	31.19	3.50	2.49	2.03	2.71	0.79	0.45	1.47	0.57	0.68
Perineurial Cells, donor2	11579-120F4	25.67	5.43	0.74	1.66	0.83	0.37	0.83	1.38	1.10	0.46
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	74.59	25.82	3.82	7.33	30.92	5.10	3.82	10.84	1.59	1.27
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	44.08	14.45	1.22	4.90	13.22	2.69	1.71	5.39	1.47	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	35.72	15.40	1.16	4.27	16.31	2.07	1.81	4.01	1.42	0.52
Placental Epithelial Cells, donor1	11278-116H9	4.54	1.91	0.48	0.48	0.24	0.24	0.24	0.72	0.24	0.00
Placental Epithelial Cells, donor2	11355-117H5	3.33	0.00	2.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	4.32	0.79	0.59	0.59	0.20	0.59	0.20	0.00	0.20	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	5.70	1.90	0.63	0.32	0.00	0.63	0.32	0.00	0.32	0.00
Preadipocyte - breast, donor1	11467-119B9	10.50	3.00	0.19	1.13	0.19	0.94	0.19	0.75	0.75	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	29.50	6.13	1.31	1.31	1.96	1.17	0.52	1.96	1.44	0.00
Preadipocyte - breast, donor2	11328-117E5	8.56	2.93	0.00	1.80	1.58	0.45	0.00	0.23	1.13	0.00
Preadipocyte - omental, donor1	11468-119C1	13.43	3.30	0.21	0.53	0.53	1.28	0.32	0.85	1.07	0.11
Preadipocyte - omental, donor2	11329-117E6	12.66	1.75	0.44	1.75	0.87	0.00	0.44	0.44	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	8.59	3.72	0.00	1.15	1.29	0.72	0.29	0.72	1.43	0.00
Preadipocyte - perirenal, donor1	11469-119C2	1.97	0.00	0.00	0.98	0.00	0.98	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	6.45	0.92	0.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	22.13	7.44	1.77	2.12	0.35	0.35	0.18	1.77	0.35	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	11.75	2.72	1.36	0.51	0.34	0.85	0.00	0.00	0.34	0.17
Preadipocyte - visceral, donor1	11280-116I2	40.33	8.01	2.89	2.42	1.21	0.75	0.65	0.84	1.58	0.56
Preadipocyte - visceral, donor2	11357-117H7	20.25	1.38	1.38	3.22	0.00	0.46	0.00	0.46	0.92	0.00
Preadipocyte - visceral, donor3	11429-118G7	18.60	4.08	1.04	1.78	0.52	0.42	0.42	0.63	0.52	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	24.74	12.67	4.37	1.06	1.81	2.41	1.96	1.81	1.21	0.91
Prostate Epithelial Cells, donor2	11331-117E8	12.32	2.03	0.14	1.35	0.41	0.41	0.14	0.54	1.08	0.14
Prostate Epithelial Cells, donor3	11404-118D9	24.19	1.47	0.12	3.25	0.18	0.37	0.92	0.12	0.18	0.00
Prostate Stromal Cells, donor1	11254-116F3	13.21	6.15	1.71	0.57	1.03	0.91	0.46	1.59	1.94	0.23
Prostate Stromal Cells, donor2	11332-117E9	13.27	6.99	1.08	1.43	0.90	0.36	0.90	0.54	2.33	0.00
Prostate Stromal Cells, donor3	11405-118E1	11.68	3.02	0.42	0.63	0.31	0.73	0.73	0.42	1.04	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	3.28	0.00	1.09	0.73	0.00	0.36	0.00	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	25.58	3.33	2.91	2.43	0.35	0.97	0.42	0.62	0.49	0.69
Renal Epithelial Cells, donor1	11517-119H5	2.03	0.51	0.51	1.01	0.00	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	3.56	2.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	27.74	3.49	3.60	3.18	0.64	0.64	0.74	0.74	0.74	0.64
Renal Glomerular Endothelial Cells, donor1	11514-119H2	2.72	0.00	0.68	0.00	0.68	0.00	0.00	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	4.85	0.67	0.54	0.94	0.13	0.00	0.27	0.00	0.00	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	20.65	7.10	5.33	3.55	1.78	0.67	0.22	1.55	1.33	0.67
Renal Glomerular Endothelial Cells, donor4	11783-124B1	0.67	2.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	5.28	0.66	0.66	0.44	0.22	0.00	0.44	0.00	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	3.13	0.63	0.00	0.63	0.00	0.00	0.63	0.63	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	2.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.55	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	11.01	1.07	0.81	1.34	0.00	0.27	0.27	0.00	0.54	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	6.33	0.00	0.00	0.84	0.00	0.00	0.00	0.42	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	3.47	0.96	0.39	0.19	0.39	0.19	0.39	0.00	0.39	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	30.34	2.59	2.85	2.33	0.52	0.78	0.26	0.78	0.52	0.78
Retinal Pigment Epithelial Cells, donor1	11528-119I7	5.40	1.14	0.57	1.14	0.28	0.28	0.00	0.28	0.00	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	3.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	18.57	4.27	0.00	5.27	0.25	0.75	1.51	0.00	0.50	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	68.69	16.57	2.41	7.62	1.74	5.21	1.07	1.47	1.07	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	61.64	5.36	6.25	3.57	0.89	0.00	0.00	1.79	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	143.10	21.46	20.91	8.81	1.65	2.20	9.91	1.65	2.20	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	116.59	24.94	19.14	16.24	3.48	2.32	4.06	2.32	1.16	4.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	64.10	8.45	21.32	7.54	2.21	0.26	3.12	4.03	0.13	3.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	37.24	10.23	8.64	4.97	2.28	0.60	1.89	0.89	0.40	1.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	61.46	9.70	15.95	6.80	2.45	1.45	2.79	2.57	0.45	2.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	61.15	7.94	15.88	9.55	2.60	0.12	2.11	2.60	0.87	2.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	43.24	8.04	8.97	7.11	1.40	0.58	1.86	1.17	0.00	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	55.47	10.86	15.02	10.86	3.24	0.46	1.39	1.85	0.46	2.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	50.38	4.52	12.18	5.34	2.19	0.00	3.01	0.82	0.27	1.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	43.87	9.08	11.65	4.69	1.21	0.61	2.72	0.76	0.15	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	39.06	8.60	11.83	5.02	1.61	0.54	2.69	1.08	0.36	1.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	41.75	2.87	9.18	5.02	1.29	0.14	1.29	1.29	0.29	1.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	34.23	8.69	8.05	5.58	0.97	1.07	1.82	1.50	0.32	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	40.05	9.07	10.18	7.74	1.33	1.11	2.21	0.66	0.22	2.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	51.43	4.40	15.49	8.99	1.34	0.19	3.44	2.29	0.19	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	40.43	8.48	10.15	6.61	1.77	0.75	1.40	2.05	0.56	1.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	66.33	14.47	20.67	6.76	2.07	1.13	2.82	1.69	0.75	3.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	49.10	5.57	15.26	8.76	1.59	0.53	2.52	1.99	0.40	1.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	48.48	11.00	8.18	6.04	1.95	0.97	2.24	1.56	0.29	1.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	44.88	8.21	10.12	9.55	1.15	0.57	1.53	0.95	0.19	1.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	43.89	5.87	13.24	7.90	1.39	0.96	1.92	1.71	0.21	1.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	37.56	7.29	13.45	6.73	1.40	0.56	1.68	1.40	0.00	2.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	40.50	11.11	11.96	8.72	2.39	0.85	2.05	1.37	1.20	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	46.86	5.47	11.85	7.48	1.64	0.36	1.09	2.01	0.55	2.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	32.62	6.87	8.83	5.52	2.21	0.61	1.96	1.47	0.37	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	39.22	11.28	8.33	5.10	2.15	1.34	0.67	1.34	0.54	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	39.15	4.48	12.97	6.84	0.47	0.24	2.12	0.71	0.00	2.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	39.48	8.53	8.93	6.35	1.79	0.99	1.19	0.99	0.00	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	37.42	6.31	14.03	8.42	1.87	0.94	2.10	0.94	0.70	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	31.93	2.49	9.54	5.81	1.87	0.41	1.87	1.45	0.00	1.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	39.38	10.18	12.83	10.18	1.33	0.66	2.88	1.77	1.11	2.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	34.26	8.77	9.82	5.43	3.34	1.04	1.67	1.46	0.21	1.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	36.74	5.52	9.42	5.79	2.42	0.54	2.56	1.62	0.81	2.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	36.10	13.45	9.54	7.32	4.94	1.19	1.19	1.19	0.85	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	39.33	10.80	10.60	7.71	2.70	1.93	0.96	0.96	0.58	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	38.17	4.99	14.10	6.36	1.55	0.86	1.55	1.20	0.34	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	30.31	11.52	6.17	7.27	5.62	0.96	0.96	2.47	0.82	1.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	39.24	12.64	15.27	10.51	1.81	0.99	2.46	2.13	0.66	2.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	46.87	3.24	14.49	6.65	0.85	0.00	2.22	1.02	0.51	2.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	43.50	7.99	12.58	4.14	2.07	0.44	2.07	1.63	0.74	1.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	43.98	6.40	10.66	6.93	2.40	1.33	2.13	1.07	0.53	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	61.11	6.36	12.17	6.78	1.52	0.41	2.07	1.24	0.41	2.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	40.72	5.95	6.67	4.29	0.95	0.71	2.14	0.71	0.95	1.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	64.69	9.67	11.49	11.49	1.41	0.60	1.81	2.02	0.20	3.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	50.95	4.24	11.02	6.22	1.04	0.57	2.54	1.13	0.09	1.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	54.50	8.04	10.48	15.37	0.70	1.05	1.75	1.40	1.05	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	55.91	12.39	8.76	9.07	0.60	0.91	2.72	0.91	1.51	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	47.49	2.20	9.55	6.12	0.86	0.00	1.71	1.35	0.49	1.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	117.75	22.71	26.20	14.41	4.08	2.04	5.09	4.22	1.16	4.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	48.67	7.30	9.73	7.91	1.83	1.22	3.04	0.61	1.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	44.91	3.32	14.17	9.04	0.60	0.00	1.51	0.30	0.00	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	39.36	7.24	6.11	7.46	2.04	0.45	2.94	0.23	0.00	1.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	61.11	11.38	6.29	9.29	1.20	0.90	0.90	0.90	0.00	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	40.62	3.78	8.86	4.25	1.77	0.59	4.37	1.53	0.35	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	47.81	6.19	8.75	4.27	2.13	1.07	1.49	1.49	1.07	2.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	79.93	14.42	10.82	8.41	0.60	0.60	2.40	1.80	1.20	0.60
Schwann Cells, donor1	11498-119F4	5.08	0.56	0.19	0.56	0.19	0.00	0.38	0.94	0.00	0.19
Schwann Cells, donor2	11578-120F3	17.01	0.00	6.80	3.40	0.00	0.00	0.00	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	14.68	2.19	0.66	0.66	0.88	0.22	0.00	0.66	0.44	0.22
Sebocyte, donor1	11220-116B5	12.05	1.10	0.00	2.19	0.55	0.00	0.55	0.55	0.55	0.00
Sebocyte, donor2	11301-117B5	7.35	1.38	0.00	0.46	0.00	0.00	0.00	0.00	0.92	0.00
Sebocyte, donor3	11378-118B1	5.77	1.65	0.21	0.62	0.00	0.00	0.00	0.00	0.00	0.00
Sertoli Cells, donor1	11255-116F4	16.57	4.97	3.31	1.66	1.66	1.66	0.00	4.97	0.00	0.00
Sertoli Cells, donor2	11333-117F1	16.95	2.82	0.00	2.82	0.00	5.65	0.00	0.00	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	19.36	2.38	0.53	3.70	0.35	1.50	0.44	0.53	0.44	0.26
Skeletal Muscle Cells, donor2	11358-117H8	3.61	0.00	0.00	0.00	0.72	0.00	0.00	0.00	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	9.20	0.00	1.67	1.67	0.00	0.84	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	33.78	2.83	3.61	2.04	0.63	0.79	1.10	0.47	0.47	0.47
Skeletal Muscle Cells, donor5	11455-119A6	31.22	2.82	3.42	3.27	0.74	0.30	0.74	0.59	0.30	0.74
Skeletal Muscle Cells, donor6	11459-119B1	36.94	2.46	7.85	2.00	0.62	0.62	1.08	1.85	0.00	1.08
Skeletal Muscle Satellite Cells, donor1	11240-116D7	58.84	4.28	4.28	2.77	1.26	3.53	0.63	1.26	1.51	1.51
Skeletal Muscle Satellite Cells, donor2	11321-117D7	30.25	3.71	3.85	1.28	0.43	0.57	1.57	0.29	0.71	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	29.37	5.06	5.65	2.88	2.18	1.09	0.60	1.69	0.50	1.09
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	18.37	4.13	0.59	2.53	0.93	2.11	0.25	0.76	1.69	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	5.07	2.17	0.72	0.72	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	4.82	0.41	0.28	0.28	0.41	0.28	0.00	0.14	0.00	0.14
Skin - palm, donor1	10286-104F7	56.41	16.12	0.00	26.86	2.69	0.00	2.69	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	13.12	1.73	0.29	1.15	0.29	0.29	0.14	0.58	0.58	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	88.33	4.91	4.91	3.27	0.82	0.00	2.45	0.82	1.64	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	16.49	2.60	0.39	2.08	0.26	0.26	0.26	0.39	0.52	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	34.61	3.34	0.70	1.53	0.70	0.56	0.42	0.14	1.53	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	25.74	2.95	0.28	3.94	0.14	0.98	0.98	0.70	1.97	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	107.84	11.42	3.81	8.03	1.90	1.69	0.42	2.11	3.59	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	25.78	2.62	0.07	2.62	0.30	0.45	0.22	0.37	0.67	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	10.49	0.93	0.31	1.54	1.23	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	24.90	3.56	0.67	1.78	0.67	0.00	0.67	1.78	0.44	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	5.88	1.76	0.59	0.00	0.00	0.59	0.59	0.00	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	8.62	1.33	0.44	1.10	0.66	0.22	0.00	0.44	0.66	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	2.76	0.39	0.00	0.00	0.00	0.00	0.00	0.00	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	20.09	0.77	0.00	0.00	0.00	0.00	0.00	0.00	1.55	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	22.02	6.00	1.00	2.00	0.00	1.00	6.00	1.00	2.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	6.39	1.20	0.13	0.27	0.13	0.13	0.13	0.40	0.13	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	11.53	2.88	0.44	1.77	1.11	0.89	0.22	1.11	0.89	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	17.41	2.05	0.26	1.15	0.51	0.51	0.13	0.51	0.77	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	23.77	3.91	2.60	0.65	3.26	0.33	1.95	1.63	1.63	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	20.97	3.25	2.07	0.89	1.18	0.00	0.59	0.59	0.30	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	10.96	2.14	0.28	0.57	1.00	0.28	0.57	0.14	0.43	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	2.93	0.65	0.00	0.16	0.16	0.00	0.00	0.00	0.16	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	21.31	2.74	0.00	1.83	0.30	0.61	2.13	0.61	1.22	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	13.39	1.26	0.76	0.25	0.00	0.51	0.76	0.76	0.25	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	24.48	0.00	6.12	18.36	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	3.34	0.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	15.93	5.01	2.95	1.03	1.33	0.44	1.33	0.74	1.33	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	16.14	3.44	1.51	1.08	0.22	0.43	0.00	0.22	1.08	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	17.32	4.93	1.99	0.73	0.73	0.10	0.52	0.73	0.94	0.73
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	2.63	0.46	0.00	0.15	0.15	0.46	0.00	0.00	0.31	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	3.23	1.08	0.00	0.00	1.08	0.00	0.00	1.08	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	6.57	1.79	0.30	1.20	0.00	0.30	0.60	0.60	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	3.41	0.34	0.34	0.34	0.00	0.00	0.00	0.34	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	47.51	8.17	2.20	1.57	0.79	0.79	2.59	1.41	1.10	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	17.31	2.92	0.30	1.71	1.21	1.31	0.91	0.91	2.62	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	11.38	4.55	0.46	2.05	1.37	0.23	0.46	0.68	0.91	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	4.23	0.00	0.00	0.60	0.00	0.00	0.60	0.00	0.00	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	46.36	10.33	10.86	3.44	1.85	0.00	2.12	1.06	2.12	2.65
Smooth Muscle Cells - Prostate, donor1	11257-116F6	35.82	5.73	1.73	1.73	1.07	0.40	1.86	1.73	1.33	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	15.78	4.38	0.63	0.63	0.88	1.00	0.88	0.63	1.75	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	21.81	2.28	0.25	0.51	0.51	0.51	1.01	1.01	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	20.81	4.07	0.90	1.21	1.66	0.60	0.60	1.06	1.21	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	7.50	0.00	0.00	0.75	0.75	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	19.38	2.58	0.00	0.00	0.00	0.00	3.88	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	9.30	2.79	0.00	0.00	0.00	0.47	0.47	0.00	0.00	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	7.07	3.03	0.50	0.50	0.00	0.00	0.00	1.01	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	9.40	0.94	0.00	0.00	0.94	0.31	0.31	0.31	0.63	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	3.24	0.29	0.00	0.00	0.00	0.29	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	35.66	7.00	5.33	2.00	1.67	1.42	1.33	2.50	1.50	0.92
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	27.56	3.74	0.00	0.93	0.00	0.00	0.47	0.47	1.40	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	5.61	0.72	0.29	0.86	0.14	0.29	0.00	0.14	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	8.41	1.53	0.00	0.51	0.51	0.51	0.00	0.51	0.25	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	4.14	0.75	0.38	0.75	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	33.54	3.35	2.93	0.70	1.68	1.40	0.14	1.40	1.96	0.56
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	20.95	2.43	1.09	1.01	0.67	1.17	0.34	0.50	0.92	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	2.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	3.91	0.49	0.00	0.00	0.24	0.24	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	7.95	0.66	0.44	1.55	0.22	0.00	1.10	0.88	0.66	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	29.84	3.22	2.34	1.46	0.59	0.29	1.46	0.59	0.88	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	20.60	6.03	0.78	2.14	0.00	0.58	1.75	0.58	0.58	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	12.43	3.97	0.00	1.06	0.79	0.26	0.00	0.26	0.53	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	27.90	4.09	1.49	0.74	0.00	1.12	1.12	0.37	1.86	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	22.28	5.39	0.36	0.36	0.72	0.72	0.72	0.00	0.36	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	11.92	3.41	0.57	0.00	0.00	0.00	0.00	0.28	1.14	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	21.27	4.73	3.15	1.58	0.00	0.79	0.00	1.18	1.58	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	18.03	4.83	1.02	1.27	0.25	0.00	1.78	0.25	1.27	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	28.35	2.80	1.20	0.40	0.00	0.00	0.40	0.80	1.20	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	12.12	4.18	0.00	0.84	0.00	0.00	0.42	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	16.96	3.67	0.92	0.92	0.00	0.00	1.38	0.46	0.92	0.00
Synoviocyte, donor1	11291-117A4	13.13	4.04	0.50	1.68	0.34	1.35	0.50	0.34	1.51	0.17
Synoviocyte, donor2	11368-117I9	20.95	2.68	0.50	0.84	0.17	0.50	0.50	0.00	1.01	0.17
Synoviocyte, donor3	11440-118H9	25.92	0.89	0.00	2.23	0.22	1.79	0.67	0.22	0.89	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	5.00	1.07	1.07	0.71	0.36	0.00	0.36	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	7.93	0.00	1.98	1.98	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	8.57	1.62	0.93	1.39	0.23	0.00	0.23	0.46	0.23	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	22.15	1.36	1.15	3.23	0.22	0.43	0.29	0.22	0.36	0.50
Tracheal Epithelial Cells, donor2	11369-118A1	5.03	0.00	0.39	0.77	0.00	0.00	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	5.15	0.00	0.00	0.00	0.00	0.00	0.57	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	80.33	14.64	1.72	8.24	2.21	3.57	2.71	1.60	1.35	0.62
Urethra, donor2	10319-105A4	48.56	21.58	0.00	12.59	0.00	3.60	5.40	1.80	1.80	0.00
Urothelial Cells, donor1	11520-119H8	4.52	0.00	0.00	0.53	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	3.20	0.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	4.35	0.46	0.00	0.46	0.00	0.23	0.00	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	57.51	2.01	1.34	2.90	0.00	1.11	1.56	0.67	0.22	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	164.61	11.57	8.90	11.57	8.90	5.34	11.57	7.12	1.78	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	164.41	12.87	4.29	15.73	5.72	0.00	15.73	5.72	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	93.09	14.37	2.05	13.69	10.27	4.79	4.79	3.42	0.00	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	110.88	20.66	4.13	9.64	18.25	7.23	6.20	5.85	1.38	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	92.38	13.36	2.32	8.72	11.04	8.72	5.23	4.65	0.58	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	156.19	9.37	2.08	13.54	9.37	7.29	9.37	3.12	0.00	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	172.54	10.10	1.84	11.93	8.26	5.51	9.18	11.01	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	90.38	16.43	0.91	7.30	4.56	7.30	4.56	0.91	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	23.07	4.69	11.23	3.58	0.74	1.23	2.22	0.74	1.36	0.62
Wilms' tumor cell line:HFWT	10597-108E3	18.48	7.04	0.88	1.76	0.88	0.00	0.88	1.76	1.76	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	55.30	7.26	7.82	8.66	0.84	1.12	1.12	0.28	0.28	1.68
achilles tendon, donor2	10292-104G4	51.66	8.27	0.00	12.40	8.27	0.00	0.00	2.07	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	32.38	16.06	24.22	7.65	8.92	9.69	1.27	2.80	1.27	2.04
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	93.57	18.11	38.31	24.15	3.48	7.66	1.16	3.95	1.39	6.73
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	72.29	64.22	56.62	7.24	31.34	4.04	1.54	14.01	2.97	6.17
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	82.45	11.43	32.65	13.06	7.62	2.99	0.82	4.90	2.18	6.80
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	22.21	2.25	10.12	2.25	1.69	0.56	0.84	0.28	0.00	1.41
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	63.23	8.67	12.90	1.48	7.40	2.96	2.75	1.69	1.90	2.33
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	36.20	21.23	5.44	2.18	14.97	1.91	0.82	3.54	2.99	1.09
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	70.06	0.88	12.78	4.41	0.88	1.76	3.97	0.00	0.00	1.32
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	11.43	0.00	3.27	0.00	0.41	0.00	0.00	0.41	0.41	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	67.18	4.66	12.04	20.19	3.49	2.72	1.94	1.55	2.33	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	29.26	6.62	7.54	3.31	2.58	0.37	1.29	0.37	0.18	1.66
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	58.51	0.00	11.70	0.00	11.70	0.00	7.80	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	56.93	8.60	20.22	1.86	6.27	1.39	1.16	3.25	2.79	3.72
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	48.41	27.96	19.68	2.59	8.54	0.52	3.11	4.66	1.04	1.55
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	43.84	12.57	11.69	3.21	4.09	0.88	3.21	2.34	0.88	1.46
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	33.93	11.62	6.51	0.93	2.79	0.93	3.25	1.39	0.46	1.39
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	46.47	6.99	13.16	0.82	2.06	0.41	1.65	0.82	0.41	2.47
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	13.20	2.46	2.46	3.68	1.23	0.31	0.61	0.31	0.00	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	41.39	5.12	8.11	4.27	2.99	2.13	2.13	1.71	1.28	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	45.80	4.55	8.49	1.82	3.03	2.12	0.30	2.73	0.61	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	42.12	4.57	13.00	4.33	2.41	0.96	2.17	0.00	1.93	1.68
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	42.10	2.67	10.69	10.25	0.22	0.89	3.34	0.22	0.45	1.11
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	41.36	9.01	8.01	10.34	2.33	1.00	3.00	1.33	0.33	2.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	96.63	39.02	14.87	7.43	7.43	3.72	5.57	3.72	0.00	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	40.68	19.21	3.39	1.88	11.68	0.75	0.38	5.65	1.13	1.51
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	62.80	16.14	24.86	4.80	4.36	1.74	1.74	0.87	0.87	3.93
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	33.74	29.99	13.12	0.00	33.74	9.37	1.87	7.50	3.75	1.87
adenocarcinoma cell line:IM95m	10796-110I4	37.68	6.59	1.65	16.25	0.47	2.35	0.24	0.94	1.41	0.00
adipose tissue, adult, pool1	10010-101C1	49.79	17.22	0.93	3.26	2.95	3.26	3.10	1.55	0.93	0.31
adipose, donor1	10184-103D4	120.80	17.59	33.43	4.69	0.59	5.86	9.38	3.52	0.59	4.69
adipose, donor2	10185-103D5	20.68	4.46	4.46	4.06	2.03	0.41	1.62	0.41	1.22	2.03
adipose, donor3	10186-103D6	51.46	5.45	10.89	4.90	1.36	1.09	3.00	1.09	0.82	2.72
adipose, donor4	10187-103D7	138.68	4.33	39.87	33.80	1.73	18.20	1.73	0.00	6.07	6.93
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	116.79	10.73	21.62	14.20	1.74	6.94	2.37	1.10	1.74	7.89
adrenal gland, adult, pool1	10081-102A9	3.64	7.28	0.00	7.28	3.64	0.00	0.00	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	48.69	4.67	7.20	6.54	1.33	0.40	0.80	0.93	0.00	0.93
alveolar cell carcinoma cell line:SW 1573	10708-109H6	22.15	2.50	6.43	5.00	0.00	2.50	1.07	0.00	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	30.37	2.32	0.23	5.56	0.70	3.71	0.23	0.23	0.93	0.23
amniotic membrane cells, donor2	12236-129G4	44.97	5.75	3.04	8.11	0.68	4.40	1.01	0.34	0.68	0.68
amniotic membrane cells, donor3	12237-129G5	65.40	1.47	0.29	11.78	0.59	4.12	1.18	0.29	0.59	0.00
amygdala - adult, donor10196	10167-103B5	14.23	4.74	3.56	11.86	3.56	1.19	1.19	0.00	3.56	1.19
amygdala, adult, donor10252	10151-102I7	35.28	18.86	4.26	20.28	2.43	5.47	3.24	2.64	4.26	3.24
amygdala, newborn, donor10223	10360-105E9	27.44	16.14	1.94	4.52	0.65	1.29	1.29	1.29	0.65	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	59.46	6.11	1.15	6.88	1.40	2.04	0.76	0.51	0.38	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	26.03	16.33	5.96	3.53	10.59	1.10	0.22	4.41	1.32	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	68.81	5.68	31.40	4.34	1.34	7.01	3.67	0.00	2.34	2.67
aorta, adult, pool1	10052-101G7	33.34	5.69	0.59	2.75	0.59	1.57	1.96	0.78	0.39	0.78
appendix, adult	10189-103D9	45.02	29.11	5.05	8.54	12.03	9.70	0.78	3.49	1.55	2.33
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	87.36	1.72	6.53	8.94	0.00	7.91	4.47	0.00	0.00	1.38
artery, adult	10190-103E1	31.25	19.02	0.00	6.79	1.36	2.72	2.72	0.00	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	62.87	33.46	5.94	5.36	4.06	12.17	1.74	3.62	7.39	1.45
b cell line:RPMI1788	10427-106D4	29.89	16.36	15.46	5.50	8.77	2.83	0.59	3.12	1.19	1.93
basal cell carcinoma cell line:TE 354.T	10702-109G9	11.93	4.16	0.83	2.22	0.83	0.28	0.28	0.00	0.55	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	89.90	38.70	13.00	11.91	6.55	5.95	1.39	4.07	5.16	1.39
bile duct carcinoma cell line:TFK-1	10496-107C1	28.29	10.21	0.17	9.88	1.67	1.00	0.67	1.17	0.67	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	57.04	11.74	2.24	5.59	4.47	0.56	1.68	0.56	0.56	0.00
bladder, adult, pool1	10011-101C2	87.13	24.23	1.41	5.54	2.06	3.04	4.24	2.17	1.30	0.11
blood, adult, pool1	10053-101G8	75.30	6.64	0.00	11.07	4.43	4.43	0.00	0.00	0.00	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	5.99	0.00	0.00	0.86	0.86	0.00	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	49.94	14.17	2.70	2.02	5.40	4.05	1.35	2.70	0.00	0.67
brain, adult, donor1	10084-102B3	16.40	1.03	3.08	7.18	0.00	0.00	1.03	0.00	1.03	0.00
brain, adult, pool1	10012-101C3	27.06	11.47	2.78	9.13	1.67	3.90	3.12	1.89	1.89	2.23
brain, fetal, pool1	10085-102B4	21.37	8.01	0.00	13.36	0.00	2.67	0.00	8.01	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	69.38	8.92	1.98	12.22	1.98	2.97	1.98	0.33	2.97	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	43.44	2.50	2.00	8.61	0.37	5.99	0.50	0.25	3.12	0.25
breast, adult, donor1	10080-102A8	57.45	10.10	0.63	12.00	0.63	2.53	1.89	0.63	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	32.65	4.32	2.79	3.18	0.25	3.68	0.13	1.02	0.76	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	61.84	2.16	4.02	28.14	1.24	3.09	1.55	0.00	0.93	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	49.27	9.21	5.06	3.68	0.69	2.30	0.69	0.92	0.46	1.84
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	45.51	8.47	4.36	2.91	0.48	3.15	0.73	2.18	0.48	0.73
carcinoid cell line:NCI-H1770	10703-109H1	71.47	4.23	9.40	11.75	0.00	1.88	1.41	0.00	0.00	1.88
carcinoid cell line:NCI-H727	10735-110B6	82.04	17.50	7.00	23.41	2.84	3.61	2.84	1.64	0.77	0.98
carcinoid cell line:SK-PN-DW	10719-109I8	74.79	10.14	19.01	7.61	0.63	0.32	1.90	0.00	0.32	3.80
carcinosarcoma cell line:JHUCS-1	10642-109A3	63.88	21.03	30.61	2.66	1.33	2.93	4.26	3.46	1.06	3.46
caudate nucleus - adult, donor10196	10177-103C6	43.75	9.21	5.76	14.97	1.15	6.91	3.45	0.00	1.15	3.45
caudate nucleus, adult, donor10252	10164-103B2	30.79	13.72	4.35	15.23	1.67	4.02	3.85	1.67	3.85	3.01
caudate nucleus, adult, donor10258	10379-105H1	20.63	5.35	2.29	3.82	1.53	3.82	0.76	2.29	2.29	2.29
caudate nucleus, newborn, donor10223	10354-105E3	28.93	23.07	2.93	11.35	0.73	3.66	2.56	1.46	1.10	0.73
cerebellum - adult, donor10196	10173-103C2	110.70	20.39	5.83	52.44	11.65	8.74	0.00	2.91	2.91	2.91
cerebellum, adult, donor10252	10166-103B4	102.06	31.81	7.05	60.00	9.82	5.98	4.06	6.83	2.78	4.91
cerebellum, adult, pool1	10083-102B2	45.19	5.86	2.41	14.83	1.38	2.41	3.45	2.07	0.34	1.03
cerebellum, newborn, donor10223	10357-105E6	122.88	36.53	14.95	20.76	5.81	3.32	9.13	10.79	1.66	4.15
cerebral meninges, adult	10188-103D8	25.47	13.87	2.02	2.27	2.77	4.29	2.02	2.27	1.76	1.26
cerebrospinal fluid, donor2	10294-104G6	29.97	5.85	2.19	10.96	2.92	2.92	1.46	2.19	1.46	0.00
cervical cancer cell line:D98-AH2	10552-107I3	46.30	7.05	3.74	1.58	0.58	1.29	0.72	1.73	0.29	0.14
cervical cancer cell line:ME-180	10553-107I4	123.79	5.80	10.27	9.61	0.99	10.11	2.98	0.17	2.65	1.33
cervix, adult, pool1	10013-101C4	67.61	33.18	3.57	7.35	3.36	5.14	4.20	4.20	1.47	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	40.97	10.87	2.65	1.53	4.04	2.09	3.76	2.79	0.98	0.70
chondrosarcoma cell line:SW 1353	10700-109G7	45.72	3.92	0.00	2.61	0.00	1.31	1.31	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	100.42	7.71	7.46	10.94	0.50	3.73	2.36	0.75	0.12	2.11
choriocarcinoma cell line:SCH	10785-110H2	42.51	8.99	1.48	8.26	0.74	4.31	0.62	0.49	0.99	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	51.47	3.08	3.56	9.49	0.00	3.32	0.47	0.00	0.71	0.47
chorionic membrane cells, donor1	12238-129G6	31.06	1.99	0.28	1.99	0.57	0.57	0.00	0.28	0.57	0.28
chorionic membrane cells, donor2	12239-129G7	21.68	8.55	2.09	2.59	1.09	0.70	0.40	0.99	1.29	0.00
chorionic membrane cells, donor3	12240-129G8	47.81	3.85	0.00	6.59	1.10	1.65	0.55	1.10	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	16.16	15.15	16.16	3.03	1.01	1.01	1.01	4.04	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	57.05	6.72	9.99	4.42	4.42	1.92	3.27	1.34	0.38	1.54
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	49.21	15.63	7.18	1.06	9.29	0.84	4.22	3.80	1.90	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	86.03	6.42	20.80	16.44	0.51	0.51	4.11	1.28	1.03	3.34
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	105.46	6.05	28.30	19.83	1.21	0.73	5.56	0.97	1.21	3.39
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	90.00	11.20	27.08	17.71	1.02	0.61	3.26	0.81	0.61	3.87
chronic myelogenous leukemia cell line:K562	10454-106G4	118.67	5.59	35.92	19.43	0.29	2.36	4.42	0.59	0.29	7.95
chronic myelogenous leukemia cell line:KU812	10409-106B4	69.85	30.49	22.41	2.87	12.25	3.13	2.87	9.90	6.52	2.09
clear cell carcinoma cell line:JHOC-5	10638-108I8	41.60	12.57	7.77	3.66	0.69	1.14	1.14	2.29	1.37	3.66
clear cell carcinoma cell line:TEN	10636-108I6	64.72	6.07	8.85	24.12	1.74	1.39	1.21	1.04	1.39	2.60
colon carcinoma cell line:CACO-2	10513-107D9	43.20	13.36	6.22	2.38	0.00	2.93	1.83	0.92	0.73	0.92
colon carcinoma cell line:COLO-320	10420-106C6	213.23	4.56	40.67	23.18	0.76	3.80	9.50	0.38	0.38	5.70
colon, adult, donor1	10082-102B1	33.32	3.57	0.00	13.09	1.19	4.76	0.00	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	62.28	23.38	2.47	4.11	4.35	3.29	3.76	2.94	0.47	0.47
colon, fetal, donor1	10070-101I7	105.06	15.45	2.47	14.21	1.24	1.85	4.94	1.24	0.62	1.24
common myeloid progenitor CMP, donor1	12130-128D6	68.75	32.08	4.58	0.00	22.92	9.17	13.75	9.17	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	84.56	19.55	29.75	22.10	8.50	1.27	2.97	3.82	0.00	6.80
cord blood derived cell line:COBL-a 24h infection	10453-106G3	53.88	10.72	22.64	9.96	3.47	2.11	1.06	2.57	1.21	3.92
cord blood derived cell line:COBL-a untreated	10449-106F8	54.43	11.99	23.69	10.01	4.51	0.99	1.13	2.96	0.85	3.67
corpus callosum, adult, pool1	10042-101F6	38.81	17.47	5.09	4.98	2.54	5.97	6.08	2.32	1.77	2.54
cruciate ligament, donor2	10295-104G7	75.37	17.02	3.24	18.64	1.62	2.43	2.43	3.24	1.62	0.81
diaphragm, fetal, donor1	10069-101I6	48.15	14.45	4.82	6.42	2.41	0.80	3.21	1.61	0.80	2.41
diencephalon, adult	10193-103E4	27.12	12.24	3.84	4.08	1.68	5.52	6.00	0.96	1.68	2.64
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	23.19	45.46	31.92	4.36	11.71	9.18	0.46	10.10	2.07	3.67
ductal cell carcinoma cell line:KLM-1	10438-106E6	100.01	21.54	13.08	16.16	1.28	8.98	1.28	2.31	4.62	1.28
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	58.01	26.48	6.26	3.85	3.85	1.93	2.17	3.85	0.96	2.89
ductus deferens, adult	10196-103E7	55.81	15.45	1.00	12.46	1.99	8.97	2.49	1.99	1.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	44.65	17.28	4.32	10.08	2.88	4.32	4.32	1.44	2.88	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	55.17	21.33	6.62	9.56	3.68	7.36	0.00	0.00	3.68	1.47
dura mater, adult, donor1	10041-101F5	56.32	18.66	4.13	3.47	8.75	3.06	1.98	3.63	2.23	0.91
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	86.16	32.20	10.88	21.76	7.99	2.89	8.22	3.55	1.78	4.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	56.03	17.48	17.77	8.31	4.44	1.72	6.88	1.58	1.72	3.44
embryonic pancreas cell line:1B2C6	10604-108F1	33.30	0.00	0.62	7.40	0.00	1.23	0.00	1.23	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	27.85	2.42	1.51	3.33	0.00	0.61	0.61	0.30	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	29.02	2.16	0.93	6.48	0.00	0.31	0.31	1.23	0.00	0.62
embryonic pancreas cell line:2C6	10603-108E9	28.90	3.94	1.31	2.63	0.00	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	34.19	9.05	1.68	9.72	7.71	5.36	0.34	2.01	4.36	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	56.55	6.34	2.54	6.52	0.72	0.72	1.27	0.91	0.91	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	24.77	1.29	1.13	6.91	0.32	3.38	0.64	0.32	0.64	0.16
epidermoid carcinoma cell line:A431	10426-106D3	95.49	6.45	10.34	17.12	0.89	3.22	2.45	0.78	0.56	2.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	20.90	1.65	2.42	4.73	0.22	0.55	0.33	0.11	0.22	0.55
epididymis, adult	10197-103E8	45.42	14.23	2.09	6.49	2.09	5.44	3.56	0.63	3.14	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	30.51	5.85	9.76	3.37	1.42	0.53	3.37	1.24	1.42	1.77
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	23.20	8.26	3.15	0.00	1.57	0.39	1.57	3.15	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	82.04	9.44	24.38	13.37	0.39	3.28	1.57	0.79	2.10	5.24
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	106.49	12.70	31.40	12.99	1.67	3.74	2.46	1.08	1.48	7.09
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	73.94	11.54	20.84	8.07	0.78	3.02	2.46	0.78	1.01	4.37
esophagus, adult, pool1	10015-101C6	54.26	13.06	1.59	5.52	1.17	3.29	1.91	1.27	1.27	0.53
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	27.43	24.30	4.88	2.63	12.52	3.38	3.01	4.88	9.89	0.88
eye - muscle inferior rectus, donor1	10272-104E2	41.05	12.07	0.00	12.07	2.41	2.41	0.00	9.66	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	37.88	8.42	2.10	8.42	2.10	0.00	0.00	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	20.84	5.95	1.49	17.86	1.49	2.98	1.49	1.49	0.00	0.00
eye - muscle superior, donor2	10297-104G9	41.27	14.90	3.44	8.03	1.15	2.29	0.00	1.15	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	36.43	7.29	4.37	8.74	1.46	1.46	1.46	4.37	0.00	2.91
eye, fetal, donor1	10054-101G9	60.25	8.64	2.54	9.92	0.25	6.61	7.12	0.76	1.02	1.78
fibrosarcoma cell line:HT-1080	10758-110E2	33.59	5.90	4.23	1.92	1.67	1.28	0.51	1.67	0.64	0.77
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	41.55	11.87	3.80	4.27	1.42	0.71	0.71	2.14	0.71	1.19
frontal lobe, adult, pool1	10040-101F4	36.78	9.95	2.72	7.32	2.25	5.72	3.38	2.16	2.25	1.60
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	90.37	30.93	13.81	15.01	5.70	6.00	4.20	5.10	2.70	1.20
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	36.30	7.41	1.83	2.10	1.74	0.27	0.37	1.10	1.10	0.18
gall bladder, adult	10198-103E9	29.21	8.45	0.48	2.17	1.69	0.97	1.93	1.93	0.97	0.24
gamma delta positive T cells, donor1	11937-126A2	28.99	19.86	5.91	4.29	24.16	8.59	0.54	4.29	2.15	1.07
gamma delta positive T cells, donor2	11938-126A3	24.65	22.78	3.73	7.10	23.53	7.84	1.12	4.86	1.12	1.49
gastric adenocarcinoma cell line:MKN1	10614-108G2	29.99	11.19	1.90	3.59	1.48	3.17	2.11	0.84	2.32	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	61.12	9.48	3.29	2.32	3.29	1.74	1.74	2.51	1.16	1.16
gastric cancer cell line:AZ521	10549-107H9	108.37	9.84	12.95	4.43	1.97	6.07	5.08	1.97	6.07	5.25
gastric cancer cell line:GSS	10560-108A2	61.32	1.83	1.83	1.83	0.00	0.92	0.92	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	59.86	18.73	5.48	4.57	1.14	1.60	4.80	1.83	0.00	2.06
giant cell carcinoma cell line:LU65	10487-107B1	17.44	7.46	0.80	9.06	0.57	0.46	0.00	0.92	0.34	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	55.14	6.58	3.22	4.34	2.80	0.42	1.96	0.84	0.28	0.42
glassy cell carcinoma cell line:HOKUG	10688-109F4	53.38	3.99	4.24	16.96	0.50	3.49	1.00	0.50	1.00	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	23.33	0.32	3.17	4.75	0.21	0.74	0.63	0.00	0.42	0.42
glioblastoma cell line:A172, tech_rep2	10444-106F3	24.30	0.84	2.95	3.37	0.70	0.42	0.70	0.14	0.56	0.42
glioblastoma cell line:T98G	10485-107A8	54.52	15.67	7.17	2.87	1.66	0.33	1.88	1.66	0.44	0.88
glioma cell line:GI-1	10413-106B8	51.55	6.74	6.15	1.76	0.88	0.88	5.56	1.17	1.17	1.46
globus pallidus - adult, donor10196	10175-103C4	42.28	10.20	5.10	10.20	0.73	1.46	10.93	1.46	4.37	1.46
globus pallidus, adult, donor10252	10161-103A8	66.15	28.80	6.35	18.80	4.64	5.61	9.03	1.95	4.64	3.66
globus pallidus, adult, donor10258	10367-105F7	24.65	12.32	2.74	4.11	1.37	4.11	4.11	2.74	2.74	1.37
globus pallidus, newborn, donor10223	10364-105F4	18.12	15.99	1.07	3.20	1.60	1.07	2.66	1.07	0.53	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	63.63	14.68	7.34	0.00	22.02	2.45	2.45	7.34	0.00	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	10.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	10.45	5.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	18.24	4.80	1.60	4.16	0.32	1.92	0.32	0.96	0.96	0.32
hIPS +CCl2, biol_rep1	14383-156B9	110.65	10.10	80.80	16.07	5.97	5.05	7.35	2.75	4.13	10.10
hIPS +CCl2, biol_rep2	14384-156C1	93.74	7.32	85.05	16.46	2.29	3.20	7.32	2.29	2.74	9.60
hIPS +CCl2, biol_rep3	14385-156C2	95.33	5.80	85.66	10.31	1.93	3.22	5.80	3.86	1.93	10.95
hIPS, biol_rep1	14380-156B6	56.05	2.87	83.36	8.62	7.19	7.19	7.19	0.00	0.00	10.06
hIPS, biol_rep2	14381-156B7	67.22	4.12	54.87	8.23	2.74	0.69	2.06	1.37	0.69	6.17
hIPS, biol_rep3	14382-156B8	41.93	5.52	14.35	5.52	1.10	1.10	2.21	5.52	0.00	3.31
hairy cell leukemia cell line:Mo	10712-109I1	24.14	6.03	7.18	4.02	2.30	1.44	0.29	0.86	0.57	2.30
heart - mitral valve, adult	10205-103F7	40.66	12.86	2.09	5.68	0.60	4.78	3.59	2.69	1.20	0.30
heart - pulmonic valve, adult	10206-103F8	38.96	16.47	1.31	7.32	2.61	5.23	1.31	2.09	2.09	0.78
heart - tricuspid valve, adult	10207-103F9	31.64	23.31	2.50	10.82	5.00	1.67	0.00	3.33	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	14.90	3.88	1.22	3.06	1.02	1.84	0.20	0.82	0.82	0.00
heart, adult, diseased, donor1	10051-101G6	13.20	2.13	0.43	2.55	0.00	1.28	0.00	0.43	0.00	0.00
heart, adult, pool1	10016-101C7	20.01	9.66	0.23	2.53	1.61	2.30	0.23	0.92	0.00	0.23
heart, fetal, pool1	10046-101G1	98.98	19.20	3.18	6.78	3.29	5.24	7.39	3.29	0.92	1.23
hepatic mesenchymal tumor cell line:LI90	10778-110G4	18.51	3.39	0.62	4.32	0.62	1.23	0.62	0.31	1.85	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	52.32	17.84	11.89	11.89	0.00	1.19	3.57	3.57	2.38	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	26.52	10.50	9.06	8.40	0.77	1.55	1.22	1.55	1.10	1.88
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	25.97	10.68	7.77	8.37	1.34	0.97	2.06	0.85	0.36	2.06
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	28.70	10.00	10.41	8.99	1.11	1.72	1.82	1.31	1.11	2.43
hepatoma cell line:Li-7	10484-107A7	28.14	31.81	4.11	4.00	5.89	1.56	1.45	3.56	0.89	0.67
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	35.68	17.39	14.17	3.12	5.93	1.01	0.90	2.51	0.80	2.41
hippocampus - adult, donor10196	10169-103B7	34.07	8.52	3.79	4.73	1.89	3.79	0.95	1.89	3.79	1.89
hippocampus, adult, donor10252	10153-102I9	36.53	18.98	6.33	17.96	3.47	7.35	5.51	1.63	5.31	4.90
hippocampus, adult, donor10258	10374-105G5	16.43	1.99	1.99	7.47	0.50	1.00	1.49	1.00	1.00	0.50
hippocampus, newborn, donor10223	10363-105F3	13.04	9.16	1.76	3.52	1.06	0.35	0.70	1.06	1.06	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	84.84	12.82	32.96	6.71	6.71	6.71	3.66	1.83	2.44	7.93
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	43.39	2.75	12.57	8.05	0.98	2.16	1.96	0.79	0.98	4.32
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	52.05	4.06	17.77	5.08	3.55	2.29	4.57	0.76	1.52	6.86
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	35.52	3.95	18.04	5.64	0.00	0.56	4.51	0.00	0.56	2.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	41.06	5.16	26.60	15.75	0.77	1.29	3.61	0.26	1.03	4.39
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	41.38	4.18	23.16	5.69	0.00	0.38	3.42	0.76	0.38	3.80
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	36.20	17.52	15.47	4.38	3.21	1.17	4.67	1.17	0.29	1.46
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	32.31	9.26	11.42	9.26	1.72	0.65	4.52	1.72	0.22	1.51
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	28.78	6.26	16.68	7.51	4.59	2.50	2.92	1.25	0.83	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	21.55	7.58	9.00	4.03	3.08	1.18	1.89	1.66	1.89	2.84
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	24.59	8.68	14.46	7.07	2.57	1.13	2.25	2.73	1.29	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	20.20	8.75	18.85	1.35	3.37	2.69	0.67	2.69	2.02	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	43.19	2.97	14.40	7.82	1.56	3.29	2.19	0.63	0.63	5.32
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	41.27	6.88	16.21	11.79	1.97	4.42	1.97	0.98	0.98	8.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	83.78	12.22	34.91	4.36	4.36	7.85	4.36	2.62	0.87	11.35
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	52.50	5.54	18.71	11.65	0.38	0.95	5.15	0.57	0.95	2.86
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	43.61	7.85	15.70	8.29	0.87	0.87	4.36	0.00	0.44	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	82.96	8.50	29.49	7.00	2.50	1.00	7.50	1.00	1.50	1.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	34.85	10.36	7.35	9.23	3.39	0.38	1.88	1.32	0.38	1.13
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	30.01	6.82	9.09	8.18	0.91	0.45	2.73	3.18	0.00	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	31.95	9.08	7.52	2.19	0.94	0.31	1.88	1.25	1.25	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	23.35	3.92	8.65	6.37	1.63	1.14	2.61	1.63	0.49	3.43
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	17.13	3.77	6.68	3.77	2.03	1.74	1.74	2.61	0.58	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	25.41	6.28	7.17	2.99	1.20	1.79	1.49	0.60	1.49	2.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	42.49	2.77	19.21	13.30	1.11	2.59	1.66	0.55	0.74	4.80
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	42.79	3.71	19.11	7.42	0.57	3.71	2.85	0.29	0.86	6.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	70.64	7.76	40.83	4.49	1.22	2.45	4.08	1.63	2.04	6.94
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	42.60	3.87	15.84	7.75	0.70	0.70	4.22	0.70	0.35	2.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	32.31	1.58	9.82	6.33	0.63	0.95	1.90	0.32	0.32	1.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	29.05	2.42	9.68	4.54	0.30	1.21	3.63	0.30	0.00	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	21.20	3.62	7.76	4.14	1.55	0.52	2.07	0.00	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	20.59	3.32	9.96	6.64	0.66	0.66	1.33	2.66	0.00	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	21.81	6.67	6.67	3.08	2.82	1.54	3.59	1.28	0.51	1.80
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	16.87	4.09	6.65	5.62	1.79	1.28	2.56	1.02	0.51	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	12.87	6.06	3.03	8.33	0.76	0.00	5.30	0.00	0.00	3.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	22.85	5.38	7.06	4.37	1.34	1.01	2.02	1.01	1.34	2.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	48.78	2.66	20.53	8.45	1.21	2.66	1.45	0.24	0.97	6.28
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	58.38	7.13	41.45	9.80	0.89	4.46	4.90	0.45	0.45	4.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	49.76	2.93	21.46	6.83	1.95	4.88	3.41	0.00	0.98	6.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	40.34	3.06	20.48	4.89	0.00	1.53	1.83	0.61	0.31	1.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	247.25	42.29	263.51	6.51	9.76	19.52	35.79	9.76	13.01	19.52
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	54.27	7.28	30.12	1.99	1.65	0.99	6.29	0.66	0.33	4.96
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	23.53	7.66	13.68	7.11	1.64	0.55	2.19	1.64	1.64	1.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	25.69	6.88	10.13	4.34	1.09	1.45	1.09	1.45	0.00	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	24.56	16.01	8.19	2.85	1.78	0.71	2.49	1.42	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	23.87	4.77	5.97	3.58	1.19	0.00	3.58	0.00	0.00	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	34.13	10.29	16.25	4.47	4.06	0.81	3.11	3.93	0.81	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	23.98	5.66	9.70	5.39	2.16	0.54	0.81	1.35	0.27	1.62
immature langerhans cells, donor1	11904-125F5	60.05	16.95	0.97	1.94	33.42	1.94	4.12	7.51	2.66	0.00
immature langerhans cells, donor2	11905-125F6	27.72	13.47	1.58	1.58	11.88	0.00	0.79	3.96	0.00	0.00
insula, adult, pool1	10039-101F3	22.81	8.23	2.27	2.84	1.61	3.97	2.08	1.32	1.70	0.95
keratoacanthoma cell line:HKA-1	10791-110H8	56.58	0.65	1.95	5.53	0.00	2.28	0.00	0.33	0.65	0.33
kidney, adult, pool1	10017-101C8	33.54	18.42	1.00	5.51	2.30	6.41	1.10	2.50	2.70	0.50
kidney, fetal, pool1	10045-101F9	36.78	10.75	0.92	5.23	2.33	2.90	1.34	1.63	0.50	0.35
large cell lung carcinoma cell line:IA-LM	10509-107D5	77.97	46.01	1.56	2.27	32.38	7.53	1.56	16.47	5.40	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	43.41	1.52	3.04	5.53	0.00	0.55	0.55	0.00	0.00	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	41.84	6.79	4.77	9.36	0.55	1.47	0.55	0.37	0.55	0.73
left atrium, adult, donor1	10079-102A7	25.06	3.81	0.54	2.18	0.54	0.54	1.09	0.54	0.54	0.54
left ventricle, adult, donor1	10078-102A6	21.74	3.54	0.00	9.10	0.00	1.01	0.51	1.01	1.01	0.00
leiomyoblastoma cell line:G-402	10721-110A1	23.53	12.31	7.39	3.01	2.19	1.09	1.37	1.37	0.55	0.82
leiomyoma cell line:10964C	10569-108B2	6.11	1.08	1.08	0.72	0.36	0.36	0.72	0.36	0.72	0.00
leiomyoma cell line:15242A	10570-108B3	5.98	1.09	0.54	0.00	0.00	0.00	0.00	0.00	1.09	0.54
leiomyoma cell line:15425	10571-108B4	11.17	0.97	1.70	1.46	0.49	0.24	0.73	0.97	0.97	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	47.05	17.77	9.41	7.32	3.14	0.00	2.09	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	56.90	13.34	6.14	2.60	3.90	0.47	2.24	2.36	0.35	1.65
liposarcoma cell line:KMLS-1	10782-110G8	20.78	4.37	0.62	2.66	0.47	2.50	0.47	0.94	0.62	0.16
liposarcoma cell line:SW 872	10726-110A6	43.62	8.65	8.29	6.70	1.10	2.68	0.61	0.85	1.22	1.95
liver, adult, pool1	10018-101C9	35.33	7.13	1.13	2.27	1.78	1.78	1.30	1.30	1.30	0.32
liver, fetal, pool1	10086-102B5	30.10	3.76	4.70	0.94	0.00	0.94	0.94	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	28.44	10.94	4.23	13.71	1.17	5.25	3.06	1.90	3.50	2.04
locus coeruleus, adult, donor10252	10165-103B3	43.55	11.63	2.77	14.39	2.77	5.35	4.98	1.85	2.95	2.58
locus coeruleus, adult, donor10258	10375-105G6	16.65	4.51	2.26	8.75	0.28	1.69	1.69	0.28	0.56	1.41
locus coeruleus, newborn, donor10223	10362-105F2	48.37	30.71	5.05	13.46	2.10	5.05	4.21	1.26	2.10	1.26
lung adenocarcinoma cell line:A549	10499-107C4	44.56	2.35	1.11	7.06	0.28	2.35	0.55	0.14	0.69	0.83
lung adenocarcinoma cell line:PC-14	10408-106B3	58.60	30.33	0.69	5.52	6.89	0.69	1.38	5.52	0.69	2.07
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	85.42	13.71	4.48	9.10	3.56	1.45	1.85	1.85	2.77	0.92
lung, adult, pool1	10019-101D1	60.36	19.73	1.18	4.84	10.28	3.54	2.24	3.31	0.95	0.24
lung, fetal, donor1	10068-101I5	219.76	37.96	16.27	19.12	5.71	2.85	15.13	14.27	3.14	4.28
lung, right lower lobe, adult, donor1	10075-102A3	51.32	14.66	2.75	4.58	1.83	3.21	1.83	1.37	1.83	1.83
lymph node, adult, donor1	10077-102A5	40.71	14.67	0.47	7.10	2.37	5.68	1.89	2.84	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	14.25	32.66	1.75	1.53	27.18	3.07	0.22	8.55	1.53	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	15.24	18.87	17.96	5.28	7.55	11.92	0.45	3.02	1.36	3.92
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	52.67	5.10	7.65	12.74	0.85	5.10	0.85	0.00	2.55	0.00
mature adipocyte, donor1	12231-129F8	22.20	7.99	0.44	0.00	2.66	7.10	0.00	0.89	1.78	0.00
mature adipocyte, donor2	12232-129F9	28.02	7.47	0.21	0.21	1.66	7.26	0.83	1.66	1.66	0.42
mature adipocyte, donor3	12233-129G1	28.92	13.51	0.24	0.47	1.19	8.06	0.71	1.19	0.95	0.00
mature adipocyte, donor4	12234-129G2	71.60	12.90	0.79	2.63	1.84	6.58	1.32	2.37	1.84	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	166.78	7.15	3.34	32.16	1.19	8.10	3.81	0.71	0.95	1.91
medial frontal gyrus - adult, donor10196	10170-103B8	18.05	6.77	3.38	7.90	2.26	7.90	2.26	0.00	1.13	2.26
medial frontal gyrus, adult, donor10252	10150-102I6	44.14	17.47	2.76	22.80	2.39	6.44	4.41	2.02	4.05	1.84
medial frontal gyrus, adult, donor10258	10368-105F8	24.14	3.49	2.86	6.99	0.64	2.86	0.95	0.32	3.49	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	30.71	34.12	2.56	5.54	4.69	5.97	3.41	2.99	5.54	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	31.05	13.50	4.22	20.93	1.86	5.40	6.24	2.03	3.71	2.03
medial temporal gyrus, adult, donor10252	10156-103A3	41.60	12.73	2.76	23.98	4.67	5.52	5.31	0.64	5.09	2.12
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	19.26	0.00	1.93	5.78	0.00	0.00	0.00	0.00	3.85	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	200.95	86.12	28.71	215.30	14.35	43.06	43.06	14.35	43.06	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	15.79	12.92	0.72	3.23	0.72	3.23	0.36	0.72	1.44	0.36
medulla oblongata - adult, donor10196	10174-103C3	49.32	11.03	6.49	12.33	1.95	5.84	5.19	3.24	3.89	0.65
medulla oblongata, adult, donor10252	10155-103A2	53.25	17.80	4.49	16.25	2.17	7.89	4.95	2.48	4.80	2.79
medulla oblongata, adult, pool1	10038-101F2	26.12	9.96	2.78	2.94	0.90	4.24	2.45	1.47	1.47	1.31
medulla oblongata, newborn, donor10223	10361-105F1	39.93	16.32	7.29	11.11	0.35	2.78	4.17	1.04	1.04	2.43
medulloblastoma cell line:D283 Med	10838-111E1	169.16	12.62	70.63	19.04	1.77	7.31	21.26	2.66	1.33	7.75
medulloblastoma cell line:ONS-76	10759-110E3	33.75	3.55	11.62	7.46	0.37	1.10	1.71	0.98	0.61	1.22
melanoma cell line:COLO 679	10514-107E1	33.06	6.90	5.46	3.59	1.58	1.15	4.46	1.58	1.01	0.86
melanoma cell line:G-361	10465-106H6	64.61	2.99	2.71	4.34	1.36	0.81	3.80	1.36	0.54	0.54
meningioma cell line:HKBMM	10691-109F7	61.69	5.97	1.27	3.62	0.72	0.18	2.89	0.90	0.00	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	78.42	29.08	34.37	16.74	2.64	5.29	0.88	5.29	0.88	10.57
merkel cell carcinoma cell line:MS-1	10844-111E7	49.77	18.40	13.74	4.41	2.59	3.37	3.63	4.67	0.78	1.81
mesenchymal precursor cell - adipose, donor1	11747-123G1	26.39	2.76	0.92	1.99	0.77	0.46	0.31	0.61	0.61	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	31.27	4.00	0.36	0.73	0.91	0.55	0.73	0.18	0.18	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	34.78	1.66	1.24	3.31	0.41	1.24	0.00	0.83	1.24	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	21.91	2.67	0.42	1.69	0.28	0.42	1.55	0.14	0.98	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	22.15	2.70	0.58	1.54	0.39	0.39	1.93	0.58	0.19	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	26.37	2.08	0.69	3.47	0.00	0.69	0.00	0.69	2.08	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	17.85	2.06	0.34	1.54	0.69	0.51	0.00	0.34	0.69	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	24.27	2.76	0.81	1.04	0.58	0.35	0.46	0.46	1.04	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	16.71	3.98	1.33	0.80	0.93	0.27	0.27	0.27	1.06	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	19.99	5.40	1.76	0.81	1.76	0.14	0.95	1.08	0.95	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	23.05	3.56	1.28	1.99	0.57	0.43	0.14	1.00	1.42	0.43
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	19.76	3.29	0.66	1.32	0.99	0.66	0.66	0.99	0.00	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	21.59	2.49	1.38	1.66	0.42	0.42	0.42	0.28	1.25	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	18.50	1.40	0.35	1.40	0.70	0.35	0.35	0.00	1.05	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	17.76	1.02	0.82	1.63	0.00	0.20	0.61	0.00	0.61	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	12.94	3.24	0.00	1.08	0.36	0.36	0.36	0.72	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	20.90	1.03	1.03	1.24	0.21	0.31	0.62	0.21	0.41	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	10.49	1.60	0.23	0.68	0.68	0.23	0.46	0.46	0.46	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	23.91	3.36	3.78	1.26	2.94	1.68	0.42	1.26	1.68	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	18.38	3.44	1.05	0.90	0.75	0.45	0.45	1.20	0.45	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	21.53	1.75	0.61	2.19	0.61	0.35	1.14	0.26	0.18	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	18.04	2.58	0.37	0.74	0.37	0.00	0.37	0.00	0.00	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	10.87	5.44	0.29	2.29	0.86	0.29	0.00	0.57	0.29	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	20.21	6.32	5.89	2.11	0.00	0.42	1.26	1.68	0.00	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	15.98	1.37	0.46	1.37	0.46	0.00	0.00	0.46	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	17.90	4.09	1.02	1.79	0.77	0.51	0.51	0.00	0.51	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	16.75	4.19	0.52	0.52	0.52	0.00	0.26	0.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	18.79	5.24	0.62	1.23	1.85	0.92	0.62	0.31	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	20.01	7.06	0.00	0.47	0.94	0.47	1.18	0.71	1.18	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	21.66	3.72	0.68	2.37	1.02	1.69	0.34	0.68	1.02	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	13.36	1.96	1.96	1.57	0.39	0.00	0.00	1.57	1.18	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	16.68	5.56	1.39	1.39	0.00	0.00	0.46	0.46	1.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	27.40	5.19	0.87	0.87	0.58	1.73	0.58	0.58	1.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	22.76	3.35	0.45	0.89	0.45	0.45	0.22	0.67	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	18.75	5.29	0.96	0.96	0.72	0.96	0.00	0.72	0.24	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	28.60	9.53	0.73	2.20	2.20	1.47	0.00	2.20	1.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	22.15	2.01	0.34	1.68	1.01	0.34	0.34	0.67	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	15.15	2.87	0.00	0.41	0.82	0.82	0.41	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	17.61	3.44	0.43	0.86	0.00	0.43	0.86	1.29	1.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	16.41	2.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	19.81	3.57	0.32	0.32	0.65	0.32	1.30	0.32	0.97	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	20.37	1.45	1.45	2.91	0.00	1.45	1.45	0.00	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	20.79	2.13	0.00	1.60	0.00	1.07	0.53	0.53	1.60	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	11.45	1.64	0.00	2.45	0.00	1.64	0.82	0.82	2.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	16.71	3.89	1.17	0.39	0.78	0.39	0.00	0.39	0.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	20.99	0.00	0.00	0.00	2.10	4.20	0.00	2.10	4.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	17.88	2.98	0.00	1.99	0.99	0.00	0.00	0.99	1.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	9.53	0.00	0.00	0.00	0.00	0.00	0.00	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	16.60	1.78	0.00	0.59	0.00	1.19	1.78	0.00	1.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	25.59	3.66	2.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00	27.05	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	19.00	3.80	0.63	1.90	1.90	0.63	0.00	1.27	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	20.00	3.10	0.00	1.03	0.69	0.34	1.03	0.69	1.72	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	10.75	6.45	0.00	0.00	0.00	2.15	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	15.97	3.99	0.00	3.99	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	3.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	16.30	2.85	0.00	0.41	0.41	0.41	0.81	0.41	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	21.45	0.79	0.00	1.59	0.00	0.00	0.00	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	17.10	0.00	0.00	2.95	0.00	1.18	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	14.96	1.25	0.31	0.94	0.31	0.31	0.94	0.00	0.62	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	13.37	4.01	0.00	0.00	0.00	1.34	0.00	0.00	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	9.46	3.55	0.00	2.37	0.00	1.18	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	9.64	2.07	0.69	0.69	0.69	0.69	0.69	0.00	2.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	11.88	7.42	0.00	5.44	0.49	0.49	0.49	1.48	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	5.61	1.12	0.00	2.24	0.00	3.36	0.00	1.12	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	9.54	4.45	0.00	1.27	0.00	1.91	0.64	1.91	1.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	2.82	2.82	0.00	2.82	0.00	0.40	0.00	0.40	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	2.18	2.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	1.27	0.00	0.00	2.53	0.00	1.27	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	12.74	2.43	0.00	1.82	0.00	0.61	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	31.63	0.00	0.00	4.52	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	11.53	3.29	0.00	1.65	0.00	0.00	0.00	0.00	1.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	13.29	2.18	0.60	1.79	0.20	0.79	1.19	0.40	0.79	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	11.68	2.60	0.00	1.95	0.00	1.30	0.00	0.00	0.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	12.22	5.09	0.00	0.00	0.00	2.04	2.04	0.00	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	17.80	7.74	0.00	0.77	0.00	0.00	0.77	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	51.74	5.67	1.89	2.60	0.47	0.00	0.47	0.47	0.00	1.18
mesothelioma cell line:ACC-MESO-4	10494-107B8	44.48	7.65	12.51	8.57	1.39	0.23	1.39	0.70	3.48	1.39
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	8.55	4.27	12.82	4.27	0.00	4.27	8.55	0.00	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	33.29	10.17	8.22	1.85	2.47	0.92	1.75	1.54	1.64	0.82
mesothelioma cell line:Mero-25	10850-111F4	15.89	8.17	4.77	2.95	3.40	0.91	0.45	0.23	1.13	0.68
mesothelioma cell line:Mero-41	10851-111F5	10.51	13.69	4.40	1.22	1.96	0.73	0.49	2.69	0.73	0.24
mesothelioma cell line:Mero-48a	10852-111F6	21.26	1.77	1.33	3.32	0.22	1.33	0.66	0.22	0.66	0.00
mesothelioma cell line:Mero-82	10853-111F7	26.02	6.83	2.89	2.89	1.05	0.26	2.63	0.26	0.53	0.53
mesothelioma cell line:Mero-83	10854-111F8	26.72	4.60	1.87	4.43	0.34	0.85	1.70	0.51	0.51	0.85
mesothelioma cell line:Mero-84	10855-111F9	13.40	1.01	4.04	1.52	0.00	0.76	0.25	0.00	0.25	0.76
mesothelioma cell line:Mero-95	10856-111G1	19.46	3.11	2.48	2.28	1.04	1.04	0.41	0.41	0.62	1.24
mesothelioma cell line:NCI-H2052	10847-111F1	26.34	3.31	4.47	2.15	0.66	0.66	0.99	0.66	0.33	0.50
mesothelioma cell line:NCI-H226	10846-111E9	18.64	4.34	3.62	2.35	0.90	0.18	0.72	1.09	0.00	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	33.99	6.15	4.10	2.05	1.37	0.68	1.20	1.37	0.17	0.17
mesothelioma cell line:NCI-H28	10845-111E8	30.79	4.33	6.62	3.31	0.25	0.51	2.04	0.76	0.76	1.53
mesothelioma cell line:No36	10857-111G2	29.36	4.24	8.48	1.96	0.00	0.98	3.26	0.33	0.33	0.98
mesothelioma cell line:ONE58	10858-111G3	24.39	2.71	1.35	4.61	1.63	0.81	1.63	0.00	0.00	0.27
migratory langerhans cells, donor1	11901-125F2	19.96	15.16	3.26	0.77	10.56	1.15	0.77	6.72	0.96	1.15
migratory langerhans cells, donor2	11902-125F3	16.00	16.36	1.95	0.61	8.67	1.22	0.00	4.88	1.22	0.85
migratory langerhans cells, donor3	11903-125F4	11.49	15.08	4.31	3.23	17.59	0.90	0.54	5.20	1.08	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	42.12	17.30	5.22	4.57	1.31	0.98	1.96	0.65	0.00	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	20.35	3.60	3.81	2.33	0.21	1.06	0.64	0.64	1.91	1.06
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	54.13	2.07	3.46	10.37	1.15	0.46	0.46	0.69	1.61	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	33.11	4.38	5.33	2.09	3.62	1.14	0.95	1.71	0.57	0.95
myelodysplastic syndrome cell line:SKM-1	10772-110F7	14.78	0.92	7.58	3.70	0.18	0.18	1.11	0.37	0.18	0.92
myeloma cell line:PCM6	10474-106I6	26.29	11.66	0.99	2.17	2.17	2.57	0.00	2.77	0.99	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	24.86	6.59	4.06	6.09	0.00	1.52	1.01	0.00	1.52	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	29.62	4.51	2.75	4.71	0.78	0.39	0.98	1.37	0.00	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	28.08	1.11	0.11	2.56	0.33	0.33	0.11	0.00	0.11	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	28.61	1.18	0.15	1.25	0.29	0.44	0.15	0.00	0.59	0.00
nasal epithelial cells, donor2	12227-129F4	70.65	3.31	8.83	11.04	0.00	4.42	0.00	0.00	1.66	0.55
neuroblastoma cell line:CHP-134	10508-107D4	63.73	4.37	7.82	9.43	0.69	8.28	1.38	0.46	0.92	1.84
neuroblastoma cell line:NB-1	10539-107G8	60.43	9.35	31.62	11.97	2.62	2.06	3.37	1.68	0.75	9.54
neuroblastoma cell line:NBsusSR	10607-108F4	50.82	5.69	5.48	3.37	3.16	2.32	2.95	1.69	1.27	1.69
neuroblastoma cell line:NH-12	10555-107I6	73.61	7.08	25.34	9.13	1.12	1.86	5.03	0.75	0.37	8.76
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	80.89	20.88	9.96	6.17	4.51	0.95	1.90	4.03	1.19	0.95
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	56.86	16.00	6.18	1.43	5.54	3.33	1.90	2.69	2.38	0.95
neuroectodermal tumor cell line:TASK1	10774-110F9	10.87	2.42	1.81	2.01	1.01	0.20	0.20	0.81	0.00	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	45.78	12.08	15.26	13.35	8.26	1.27	1.27	3.81	1.91	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	18.10	2.40	0.27	1.60	1.33	1.06	0.80	1.06	0.80	0.27
neutrophil PMN, donor1	12133-128D9	29.75	0.00	0.00	0.00	14.87	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	39.84	26.56	0.00	0.00	39.84	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	66.29	47.35	0.00	0.00	56.82	0.00	0.00	9.47	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	255.37	31.79	164.89	6.60	15.22	13.02	2.54	5.58	1.69	34.16
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	31.22	17.61	3.20	3.20	1.60	1.60	0.80	0.80	0.80	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	15.71	4.49	0.64	0.96	0.64	0.64	0.64	0.32	0.64	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	14.98	2.63	1.05	1.05	0.26	0.26	1.05	1.05	0.53	0.26
nucleus accumbens, adult, pool1	10037-101F1	27.47	9.09	2.06	4.12	1.87	3.09	2.91	1.78	2.34	1.50
occipital cortex - adult, donor10196	10172-103C1	43.27	4.12	8.24	14.42	0.00	4.12	4.12	2.06	6.18	0.00
occipital cortex, adult, donor10252	10163-103B1	52.06	19.32	5.10	33.28	2.42	7.25	7.51	3.49	4.29	2.95
occipital cortex, newborn, donor10223	10355-105E4	15.29	12.37	1.09	9.10	1.46	0.73	0.36	0.73	3.28	0.00
occipital lobe, adult, donor1	10076-102A4	23.88	8.66	2.10	6.56	0.79	4.20	2.89	1.05	2.10	1.31
occipital lobe, fetal, donor1	10073-102A1	50.20	15.45	3.00	24.03	1.29	7.72	4.29	2.57	3.00	2.57
occipital pole, adult, pool1	10036-101E9	10.41	3.55	0.55	2.44	1.02	1.58	0.95	0.95	0.47	0.47
olfactory region, adult	10195-103E6	26.17	8.22	4.20	13.18	1.72	4.20	3.63	2.10	2.48	2.87
optic nerve, donor1	10277-104E7	44.02	26.01	4.00	12.01	6.00	16.01	8.00	2.00	0.00	4.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	84.86	12.87	1.48	24.49	1.82	2.39	2.16	1.37	0.23	0.68
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	49.18	0.69	6.46	2.89	0.27	0.96	2.89	0.41	0.00	0.96
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	53.17	20.32	8.64	6.77	2.37	4.74	2.37	1.52	3.39	1.86
oral squamous cell carcinoma cell line:SAS	10544-107H4	54.06	3.12	7.28	3.12	0.58	1.04	2.08	0.23	0.46	1.27
osteoclastoma cell line:Hs 706.T	10704-109H2	18.81	5.59	1.76	2.94	0.88	0.29	0.00	0.00	0.59	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	131.74	15.88	4.67	9.34	4.67	4.67	3.74	2.80	2.80	1.87
osteosarcoma cell line:HS-Os-1	10558-107I9	44.96	11.88	2.12	3.82	2.12	1.70	1.91	1.27	0.85	0.42
ovary, adult, pool1	10020-101D2	46.12	24.72	5.59	5.07	2.36	3.76	4.45	2.18	0.61	0.35
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	21.27	3.48	2.20	3.12	1.28	0.73	0.18	1.28	0.55	0.18
pancreas, adult, donor1	10049-101G4	21.63	6.58	0.00	2.82	0.94	2.82	1.88	0.00	1.88	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	108.18	8.67	10.34	13.98	0.84	2.24	2.52	0.84	0.84	3.91
papillary adenocarcinoma cell line:8505C	10437-106E5	49.91	19.59	5.62	6.47	3.41	1.02	2.04	2.56	0.51	0.68
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	90.24	11.09	4.64	7.12	1.66	2.65	2.32	0.66	1.16	0.33
paracentral gyrus, adult, pool1	10035-101E8	19.04	5.49	1.37	2.47	1.74	3.39	2.29	1.56	1.46	0.64
parietal cortex, adult, donor10258	10373-105G4	60.92	5.87	11.01	13.95	1.47	2.94	1.47	2.20	2.20	2.20
parietal lobe - adult, donor10196	10171-103B9	43.26	8.46	6.58	17.87	1.88	4.70	3.76	0.94	2.82	0.00
parietal lobe, adult, donor10252	10157-103A4	40.76	13.40	4.56	28.22	1.14	4.56	3.14	2.28	2.57	2.00
parietal lobe, adult, pool1	10034-101E7	18.33	6.34	1.94	2.47	1.32	3.17	2.11	0.62	1.85	1.06
parietal lobe, fetal, donor1	10072-101I9	74.68	18.43	19.40	16.49	0.97	12.61	1.94	0.97	0.97	3.88
parietal lobe, newborn, donor10223	10356-105E5	17.95	9.72	1.50	4.86	1.12	2.24	2.62	2.24	1.50	0.00
parotid gland, adult	10199-103F1	22.82	9.87	0.00	1.85	0.62	3.70	1.23	1.23	1.23	0.00
penis, adult	10200-103F2	40.82	12.35	1.61	7.52	2.69	5.91	2.69	1.07	1.61	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	82.00	2.42	8.18	11.90	0.00	0.37	2.23	0.00	0.19	1.67
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	39.05	7.87	3.35	7.43	1.02	3.79	0.29	0.87	1.60	0.58
pineal gland - adult, donor10196	10179-103C8	37.41	7.10	3.23	18.71	2.58	7.74	2.58	1.29	1.29	0.00
pineal gland, adult, donor10252	10160-103A7	74.03	2.37	2.37	59.81	3.55	18.36	4.15	1.18	1.78	0.00
pineal gland, adult, donor10258	10377-105G8	32.61	6.90	0.00	9.41	0.63	9.41	1.25	0.00	2.51	0.00
pituitary gland - adult, donor10196	10180-103C9	77.91	9.11	2.02	10.12	1.01	9.11	4.05	1.01	4.05	1.01
pituitary gland, adult, donor10252	10162-103A9	125.60	8.86	3.65	38.05	2.08	21.89	4.17	1.56	2.08	1.04
pituitary gland, adult, donor10258	10378-105G9	61.29	7.66	2.55	2.55	0.00	6.81	4.26	0.00	0.85	1.70
placenta, adult, pool1	10021-101D3	59.34	9.89	1.61	5.38	3.33	5.81	0.86	1.83	0.97	0.43
plasma cell leukemia cell line:ARH-77	10840-111E3	27.02	17.75	12.71	4.24	11.79	0.79	0.66	4.11	0.53	2.25
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	60.54	9.49	2.96	11.67	1.09	1.25	1.87	1.40	1.09	0.93
pons, adult, pool1	10033-101E6	32.71	9.64	1.89	4.30	1.98	6.37	3.53	1.38	2.58	0.86
postcentral gyrus, adult, pool1	10032-101E5	15.08	3.75	1.39	2.96	0.96	2.27	1.83	1.13	0.96	0.26
promyelocytes/myelocytes PMC, donor1	12132-128D8	33.46	0.00	2.09	0.00	8.37	2.09	2.09	6.27	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	22.03	5.51	0.00	0.00	5.51	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	11.74	0.00	11.74	11.74	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	31.90	1.02	3.64	6.70	0.15	1.02	0.87	0.58	0.29	1.02
prostate cancer cell line:PC-3	10439-106E7	80.95	14.52	10.71	25.41	4.36	3.81	2.18	1.82	2.90	1.27
prostate, adult, pool1	10022-101D4	60.13	18.50	1.54	5.53	1.90	6.17	3.36	2.18	1.00	0.45
putamen, adult, donor10196	10176-103C5	33.52	13.46	4.49	9.91	1.65	6.14	1.89	1.18	5.67	1.89
putamen, adult, donor10252	10152-102I8	25.49	17.65	1.96	5.88	1.96	1.96	13.73	1.96	3.92	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	31.69	9.84	29.51	6.56	0.00	3.28	3.28	1.09	3.28	4.37
putamen, adult, donor10258, tech_rep2	10372-105G3	13.29	7.01	2.42	3.62	0.00	1.69	1.45	0.97	1.45	2.17
putamen, newborn, donor10223	10365-105F5	49.48	27.74	6.00	9.75	1.50	5.25	3.75	3.75	3.75	1.50
rectal cancer cell line:TT1TKB	10469-106I1	63.42	14.26	3.49	8.15	1.16	1.16	3.78	1.16	0.87	1.16
rectum, fetal, donor1	10067-101I4	91.81	23.65	6.95	13.91	4.17	9.74	0.00	2.78	1.39	4.17
renal cell carcinoma cell line:OS-RC-2	10411-106B6	30.74	5.51	4.88	2.97	0.42	1.06	0.42	0.00	0.00	0.85
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	77.87	3.73	0.83	3.73	2.07	0.00	1.66	0.83	0.00	1.24
retina, adult, pool1	10030-101E3	41.25	7.75	1.99	5.07	1.19	4.17	4.67	0.89	1.79	0.70
retinoblastoma cell line:Y79	10475-106I7	179.26	12.21	74.82	27.80	1.30	5.98	16.63	2.34	2.34	12.73
rhabdomyosarcoma cell line:KYM-1	10787-110H4	27.17	3.57	9.59	3.57	1.60	1.35	1.35	0.98	0.86	0.86
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	189.81	82.39	58.49	21.65	20.25	6.19	5.34	16.31	4.22	8.72
sacrococcigeal teratoma cell line:HTST	10695-109G2	23.49	6.82	0.00	0.76	3.03	1.52	3.03	1.52	3.79	1.52
salivary acinar cells, donor1	11771-123I7	42.24	2.75	1.62	3.56	0.49	0.81	2.43	0.16	1.29	0.16
salivary acinar cells, donor2	11772-123I8	41.86	2.20	0.41	2.89	0.14	0.96	2.75	0.14	0.41	0.28
salivary acinar cells, donor3	11773-123I9	39.06	6.62	0.66	11.25	1.32	2.65	5.96	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	29.17	6.86	0.57	2.86	0.57	2.86	0.57	2.29	1.14	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	77.82	9.53	4.81	3.46	1.52	1.60	2.45	0.93	0.59	0.67
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	80.64	9.64	3.06	4.23	2.23	1.88	3.06	1.18	0.35	0.24
seminal vesicle, adult	10201-103F3	58.20	15.87	2.65	10.58	2.12	11.11	2.12	3.17	2.65	3.17
serous adenocarcinoma cell line:JHOS-2	10639-108I9	33.04	16.52	1.21	1.70	1.21	2.67	1.46	1.21	1.94	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	13.08	2.01	0.50	1.51	1.01	0.50	0.25	0.25	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	23.08	4.01	3.01	5.02	0.00	0.00	0.00	1.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	48.62	8.46	0.94	5.78	0.27	3.49	1.48	0.54	0.13	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	53.61	12.49	3.32	9.84	1.44	2.87	1.77	1.11	0.66	0.77
signet ring carcinoma cell line:NUGC-4	10483-107A6	57.16	5.16	2.84	10.97	0.90	2.45	1.29	0.52	1.29	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	43.98	12.06	0.71	4.97	0.71	2.84	4.26	2.84	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	56.85	12.35	1.20	4.68	1.80	2.04	3.24	1.56	0.84	0.36
skeletal muscle, fetal, donor1	10066-101I3	42.21	5.03	1.01	2.01	2.01	4.02	6.03	0.00	0.00	1.01
skin, adult, donor1	10074-102A2	54.28	0.00	0.00	13.57	0.00	6.79	6.79	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	87.74	10.73	5.68	8.21	3.16	7.57	3.79	3.16	3.79	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	48.36	6.34	11.34	4.67	2.00	4.34	1.67	2.67	2.00	1.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	89.20	20.80	10.72	27.11	3.78	2.52	3.78	1.89	1.58	3.47
small cell lung carcinoma cell line:DMS 144	10841-111E4	45.49	8.29	22.74	4.43	0.77	2.70	2.31	0.00	1.93	9.25
small cell lung carcinoma cell line:LK-2	10541-107H1	84.89	6.59	11.37	51.43	2.64	3.13	2.14	1.15	0.82	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	208.46	1.29	22.52	61.12	0.64	0.16	8.36	0.00	0.00	5.47
small cell lung carcinoma cell line:WA-hT	10562-108A4	88.04	3.49	12.86	20.48	0.44	6.76	2.83	0.65	2.62	2.18
small intestine, adult, pool1	10024-101D6	61.27	16.01	2.03	7.88	3.70	6.09	2.27	1.91	2.15	0.36
small intestine, fetal, donor1	10064-101I1	31.69	13.02	2.95	6.88	1.72	3.93	1.97	1.72	1.72	0.98
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	59.50	21.54	3.08	1.03	2.05	1.03	2.05	2.05	0.51	0.51
smooth muscle, adult, pool1	10048-101G3	52.98	14.99	1.55	2.84	2.07	3.62	4.14	1.55	0.52	0.52
somatostatinoma cell line:QGP-1	10781-110G7	67.81	2.41	0.27	9.92	1.07	3.75	2.14	0.27	0.54	0.00
spinal cord - adult, donor10196	10181-103D1	57.81	19.96	5.05	24.55	1.15	11.93	5.28	2.52	6.19	4.13
spinal cord, adult, donor10252	10159-103A6	73.73	17.35	9.86	18.53	4.34	7.10	13.01	2.76	3.55	7.49
spinal cord, adult, donor10258	10369-105F9	28.36	11.07	11.76	7.61	2.77	2.08	6.23	2.77	4.84	3.46
spinal cord, fetal, donor1	10056-101H2	34.15	4.88	2.44	8.54	1.22	5.49	1.83	0.61	1.22	0.61
spinal cord, newborn, donor10223	10359-105E8	63.37	42.71	5.51	4.59	4.59	7.81	11.02	4.13	2.76	5.51
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	16.88	4.93	1.34	2.09	0.75	1.05	0.30	0.60	2.54	0.00
spleen, adult, pool1	10025-101D7	37.56	24.34	2.20	3.19	13.33	4.96	1.98	6.17	1.98	0.55
spleen, fetal, pool1	10044-101F8	42.83	16.29	2.86	3.42	4.69	1.83	2.46	2.22	1.03	1.03
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	51.34	26.91	15.01	2.28	17.60	2.69	1.55	8.90	1.35	1.97
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	59.62	5.32	2.66	13.48	0.76	2.09	0.38	0.76	1.52	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	25.16	5.59	4.54	4.54	0.35	2.10	0.70	1.05	2.45	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	69.19	9.38	2.35	6.65	3.91	1.17	1.17	1.95	0.78	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	30.28	17.11	1.01	6.08	3.04	3.94	0.56	2.48	2.59	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	70.32	7.62	20.76	7.62	0.00	2.12	1.69	0.42	1.69	1.69
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	91.38	7.19	16.08	6.35	2.12	0.00	1.27	0.85	0.85	3.38
stomach, fetal, donor1	10062-101H8	54.47	19.22	0.00	4.27	0.00	0.00	1.07	1.07	1.07	0.00
submaxillary gland, adult	10202-103F4	33.04	13.10	0.57	13.10	3.99	6.27	1.14	0.57	1.71	0.57
substantia nigra - adult, donor10196	10178-103C7	162.82	0.00	0.00	0.00	0.00	0.00	108.55	0.00	0.00	54.27
substantia nigra, adult, donor10252	10158-103A5	62.73	17.66	4.15	10.59	2.70	4.98	8.52	1.66	2.28	2.08
substantia nigra, adult, donor10258	10371-105G2	22.24	5.69	5.69	5.17	1.55	4.66	3.62	2.59	0.52	1.03
substantia nigra, newborn, donor10223	10358-105E7	60.77	16.96	0.71	6.36	3.53	1.41	6.36	0.00	1.41	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	105.92	17.88	23.61	4.13	1.83	4.81	2.52	4.59	3.21	5.04
temporal lobe, adult, pool1	10031-101E4	11.27	4.83	0.93	2.37	0.25	2.03	1.27	0.85	0.76	0.42
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	31.34	14.96	3.56	13.53	0.71	7.12	2.85	2.14	3.56	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	26.81	12.31	5.27	11.43	0.44	3.52	1.76	2.20	0.88	0.44
tenocyte, donor1	11763-123H8	18.15	1.75	0.70	1.40	0.70	0.70	1.05	0.35	2.44	0.35
tenocyte, donor2	11765-123I1	26.32	2.29	0.76	1.14	1.14	0.76	1.53	0.00	0.38	0.00
tenocyte, donor3	11768-123I4	16.31	1.85	1.11	1.48	0.37	0.37	0.74	0.00	0.37	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	125.77	22.09	35.69	13.26	7.82	3.74	2.55	4.08	1.19	9.18
teratocarcinoma cell line:NCR-G1	10798-110I6	35.30	24.66	7.24	3.55	5.24	1.54	1.70	4.62	1.08	2.31
teratocarcinoma cell line:PA-1	10807-111A6	50.99	2.63	11.93	4.03	3.25	2.01	2.32	0.46	0.46	1.55
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	89.37	28.69	13.46	5.08	11.04	3.81	3.17	5.71	2.16	2.67
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	206.48	33.66	32.52	57.10	5.67	4.16	7.56	4.92	0.38	10.21
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	176.90	31.96	17.12	14.18	4.36	1.31	8.29	4.91	2.07	4.25
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	107.16	36.80	13.35	12.05	9.45	1.95	6.84	10.10	0.98	2.28
testis, adult, pool1	10026-101D8	28.02	13.85	0.75	7.95	1.93	3.01	2.36	1.72	0.75	0.11
testis, adult, pool2	10096-102C6	11.28	6.32	2.26	9.02	0.90	0.45	0.00	0.00	0.00	0.45
thalamus - adult, donor10196	10168-103B6	41.95	16.56	4.42	12.14	2.21	4.42	5.52	4.42	4.42	2.21
thalamus, adult, donor10252	10154-103A1	62.04	25.16	5.00	13.75	2.03	6.10	7.97	2.19	4.22	3.91
thalamus, adult, donor10258, tech_rep1	10370-105G1	21.55	0.00	4.62	6.16	1.54	0.00	3.08	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	13.34	4.28	1.15	4.12	0.33	1.48	2.31	0.16	1.32	1.65
thalamus, newborn, donor10223	10366-105F6	21.86	9.78	1.73	6.90	1.73	1.15	0.58	1.15	1.15	1.15
throat, adult	10209-103G2	35.95	10.24	1.75	8.74	1.75	3.75	2.25	2.00	0.25	0.25
throat, fetal, donor1	10061-101H7	63.99	19.81	9.75	8.23	3.05	5.79	6.40	3.35	4.27	2.13
thymic carcinoma cell line:Ty-82	10803-111A2	51.87	11.53	14.71	4.57	0.99	2.19	1.39	0.60	1.59	1.99
thymus, adult, pool1	10027-101D9	73.77	60.44	51.10	13.22	29.13	13.12	1.19	13.72	9.84	9.25
thymus, fetal, pool1	10043-101F7	88.63	54.97	46.86	13.92	27.85	11.12	2.29	14.55	8.42	9.14
thyroid carcinoma cell line:KHM-5M	10776-110G2	62.36	7.45	10.90	7.05	0.66	1.99	1.86	1.33	0.66	1.99
thyroid carcinoma cell line:TCO-1	10783-110G9	53.92	10.20	5.45	6.71	2.10	1.12	2.51	1.82	1.26	0.70
thyroid, adult, pool1	10028-101E1	57.95	21.00	2.80	11.48	2.71	10.36	1.68	2.89	4.57	0.28
thyroid, fetal, donor1	10060-101H6	49.30	15.29	2.11	11.86	2.64	11.07	1.58	5.54	4.48	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	52.35	21.56	3.08	3.08	3.08	0.00	3.08	0.00	0.00	0.00
tongue, adult	10203-103F5	37.44	11.16	0.93	6.05	2.33	2.33	2.79	1.63	0.47	0.70
tongue, fetal, donor1	10059-101H5	60.69	7.09	1.97	6.31	0.39	5.12	3.15	0.39	1.18	0.00
tonsil, adult, pool1	10047-101G2	30.45	15.13	2.80	4.21	9.22	4.31	0.20	3.81	1.10	0.50
trachea, adult, pool1	10029-101E2	47.20	14.15	2.21	7.12	2.45	3.93	1.64	2.29	0.98	0.49
trachea, fetal, donor1	10058-101H4	72.32	16.93	5.00	8.08	1.15	5.39	3.85	4.23	2.31	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	19.13	5.31	1.42	2.13	0.71	1.06	0.00	0.71	2.13	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	95.34	12.56	43.26	7.80	1.93	3.04	3.24	1.93	2.23	6.18
transitional-cell carcinoma cell line:JMSU1	10492-107B6	51.86	12.06	8.62	4.86	1.41	0.31	1.57	0.78	0.63	2.19
tridermal teratoma cell line:HGRT	10694-109G1	34.25	1.90	11.42	0.00	5.71	0.00	3.81	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	35.05	11.77	1.44	2.20	3.22	2.03	0.85	1.86	1.27	0.17
umbilical cord, fetal, donor1	10057-101H3	22.95	2.09	0.00	8.35	0.00	2.09	0.00	2.09	2.09	0.00
uterus, adult, pool1	10100-102D1	64.67	12.46	3.58	4.95	1.71	2.56	7.68	4.27	1.37	0.51
uterus, fetal, donor1	10055-101H1	87.54	13.82	5.63	10.75	1.02	6.66	3.07	3.07	2.56	1.54
vagina, adult	10204-103F6	79.48	21.32	1.29	10.99	2.58	1.29	3.88	2.58	0.00	1.29
vein, adult	10191-103E2	27.84	16.44	2.41	5.26	6.36	3.07	1.53	1.53	1.32	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	11.75	8.01	2.67	2.14	4.81	0.53	0.00	2.40	0.53	0.27

Property "Nearest transcripts" (as page type) with input value "NM_001375377.1:20 NM_001375372.1:20 ENST00000435215.5:56 ENST00000471107.1:-188 ENST00000466748.5:-236 BC001765:-254 ENST00000458176.5:-272 ENST00000371144.7:-272 BX641003:-272 BX641002:-273 CR749433:-273 AL831939:-273 ENST00000371157.7:-293 ENST00000371145.8:-305 NM_006603.5:-305 NM_001375371.1:-305 NM_001042751.2:-305 NM_001042750.2:-305" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.